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 My dissertation focuses on advancing the development and application of ambient 
ionization mass spectrometry methodology and technology to the biomedical field. The 
primary ambient ionization method used in my studies is desorption electrospray ionization 
mass spectrometry (DESI-MS) imaging, which has been previously used to analyze and 
differentiate disease state (i.e. tumor and normal) and in some cases tumor subtype of 
human liver, kidney, bladder, testicular, prostate, and brain cancers. DESI-MS imaging is 
an ideal method for disease diagnosis, because it can be used to directly correlate disease 
state with histopathology to develop and validate MS libraries built using the molecular 
profiles that relate to tissue disease states. The goal of this research is to use ambient 
ionization mass spectrometry for intraoperative surgical-guidance to more accurately 
diagnose tissue and reduce surgical times. 
Technological developments during the course of research revolved around touch 
spray ambient ionization mass spectrometry (TS-MS). This method uses a small probe (e.g. 
teasing needle) to pick up a minuscule amount of material from a sample, transfer the probe 
to the front of a mass spectrometer, and, with the addition of high voltage and solvent, 
induce ESI-like mechanisms for ionization. An evaluation of TS for its use as a 
xv 
 
potential in vivo surgical tool for disease screening was performed by concurrently 
studying prostate cancer tissue obtained from surgery with DESI-MS imaging. DESI 
imaging was used to first establish the relationship between MS molecular profiles and 
pathology which were then targeted using TS. Further, TS was also evaluated as a non-
targeted technique by analyzing prostate specimens with unknown disease states and 
comparing the unknown data to the previously built MS targeted library. 
Methodological developments include DESI-MS studies for preliminary diagnosis 
of disease state and tumor subtyping using fine needle aspirations (FNA) of canine 
lymphoma specimens. Lipid profiles obtained from FNA samples were tested against a MS 
library built from a matched set of surgical tissue sections with disease states confirmed by 
histopathology. DESI-MS imaging was also used to expand upon previously investigated 
human kidney cancer. Previous investigations included two subtypes and low sample 
numbers (~10 paired normal and tumor samples per subtype), this more recent study 
includes the top three most commonly diagnosed subtypes (clear cell, papillary, and 
chromophobe) and higher sample numbers (~20 paired normal and tumor samples per 
subtype). 
In summary, many methodological and technological advances were made during 
the course of my dissertation studies. These advances include the development of a novel 
ambient ionization method, an extension of current applications to include FNA samples 
for early diagnosis, and an expansion of previous work to build more complex and 
comprehensive MS libraries. Advances such as these continue to propel ambient ionization 
mass spectrometry deeper into the biomedical field and gives hope to the use of chemical 
profiling using these methods for biomedical applications in the near future. 
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CHAPTER 1. INTRODUCTION 
1.1 Mass Spectrometry Imaging 
Molecular imaging is a continuously growing field in mass spectrometry (MS) with 
interest from persons in many areas of scientific research. The combination of detailed 
chemical information from MS and the spatial distribution of those chemicals in the form 
of a digital image provides information which was previously under- or uninvestigated.  
Although MS imaging has a long history dating back to the early 1960’s, major interest did 
not occur until the 1990’s.1,2 This interest was primarily due to two MS ionization 
techniques, secondary ion mass spectrometry (SIMS)3 and matrix assisted laser desorption 
ionization (MALDI).4 Each ionization technique is responsible for its share of MS imaging 
success, SIMS initially due to its biological applications with high spatial resolution and 
MALDI initially due to its powerful combination with a time of flight mass spectrometer. 
These developments and others pushed MS imaging into numerous fields of promising 
research such as, forensic sciences, material sciences, and biomedical sciences.5-7 One 
promising application of MS imaging to date has been disease diagnosis where multiple 
MS imaging methods have shown correlation of molecular information and disease state.8 
The molecular information may serve as a complementary technique to standard 
pathological evaluation of disease state.  
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SIMS is carried out under vacuum using a primary ion beam of kiloelectron volt 
(keV) energy to bombard and eject secondary ions from a surface that are analyzed by a 
MS. Traditionally, there are primarily two operational modes of SIMS, static SIMS and 
dynamic SIMS, which are categorized by the current density of the primary ion beam. 
Dynamic SIMS utilizes a high current density ion beam (>1013 ions/cm2) and static SIMS 
a low current density ion beam (<1013 ions/cm2). Each mode produces different SIMS 
results, dynamic SIMS conditions result in a more destructive environment where the 
primary ion beam will cause surface sputtering allowing a depth profile (nanometers to 
micrometers) to a sample by successively eroding the sample surface, but due to the high 
current conditions will primarily generate elemental and small cluster secondary ions for 
analysis. Alternatively, the low current primary ion beam of static SIMS allows structurally 
intact organic secondary ions to be generated and for minimal damage to a samples surface, 
making this mode minimally destructive.9,10 Technological and methodological advances 
such as time-of-flight (ToF) mass analyzers and cluster ion sources continue to increase 
SIMS sensitivity and usefulness for complex samples and low concentration analytes. 
Development of different cluster ion and polyatomic ion sources have paved the way for 
biological imaging with SIMS by reducing chemical damage to samples, reducing 
secondary ion fragmentation, and also increasing secondary ion yields. Possibly the most 
important and distinguishing feature of SIMS is the high spatial resolution compared to 
that of other imaging methods.9,11 SIMS is regularly reported with sub-micrometer spatial 
resolution and has been reported to produce distributions of biochemical compounds at 
spatial resolutions of 100 nm and below.12 
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Similar to SIMS, MALDI is also normally performed under vacuum, however 
MALDI utilizes UV/IR laser pulses instead of a primary ion beam to interrogate the sample 
surface. MALDI also uses an organic matrix which is applied to the sample prior to analysis 
to help with desorption and ionization. The mechanism of ionization by this method is still 
greatly debated. Although the exact mechanism is not known, it is known that the type of 
organic matrix used and the application of said matrix to a sample can strongly affect the 
quality of MALDI images.10 One major effect MALDI matrices can have is the ability to 
resolve different chemical classes, thus a major effort has been put forth to develop 
matrices for specific chemical classes including larger biomolecules (e.g. proteins and 
peptides) and smaller biomolecules (e.g. lipids and metabolites), as well as illicit and 
therapeutic drugs.13-15 Although spatial resolution of MALDI imaging is inherently limited 
by the laser’s focal diameter, displacement of analytes during matrix deposition is the other 
main limiting factor.16 However, developments in matrix deposition as well as laser optics 
make spatial resolution of single eukaryotic cells achievable by MALDI imaging. In 
contrast to SIMS, MALDI is considered a soft ionization technique (i.e. little to no 
fragmentation) which primarily produces singly protonated ions or alkali metal adducted 
ions. The most successful application of MALDI imaging has been its use in peptide and 
protein studies for cancer diagnosis. One of the first such works reported on the molecular 
changes of peptides and proteins in different regions of a human glioblastoma tumor from 
nude mouse xenograft tissue sections.13 MALDI imaging has been used to study cancers 
from animal subjects to human subjects and has been used to investigate many complex 
biological matrices including different tissue types, whole blood, blood serum, blood 
plasma, saliva, and urine.17  Although cancer studies by MALDI imaging are some of the 
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more well-known studies, MALDI has also been used to study the proteome of other 
diseases such as neurodegenerative diseases, Alzheimer’s and Parkinson’s.18,19 Aside from 
studies related to disease, MALDI imaging has also been used to examine different 
therapeutic drug processes, for example to map distribution changes of a drug and its 
metabolites in tissue when the drug was administered at differing dosages.20  
The development of ambient ionization techniques caused an expansion in MS 
imaging applications. Specifically, a surge in clinical imaging applications was caused by 
the development of ambient ionization MS where one main goal is to provide real-time 
information on disease state during surgical procedures.21,22 The possibility of this 
application and many like it is due to the nature of ambient ionization methodology where 
unlike conventional SIMS and MALDI, ambient ionization techniques do not require 
sample introduction into a vacuum or sample pre-treatment such as the addition of organic 
matrices. Analysis by ambient ionization techniques is performed with little to no sample 
preparation and in the ambient environment allowing for molecular information to 
collected within seconds.23 The use of ambient ionization MS imaging for applications of 
diagnosis has been extensively studied and successfully demonstrated by desorption 
electrospray ionization (DESI), the most well-known and commonly used ambient 
ionization technique. 
 
1.2 Ambient Ionization Mass Spectrometry 
The introduction of ambient ionization techniques began in 2004 with the 
development of desorption electrospray ionization or DESI.24 Since its development, 
ambient ionization has expanded to include many different techniques which can be 
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subcategorized based on each technique’s method of desorption and ionization. The three 
main categories are: Liquid extraction methods, spallation methods, and thermal desorption 
methods.25  
Liquid extraction methods are by far the largest group of ambient ionization 
techniques and can be further broken down into the groups of spray desorption, substrate 
spray, and liquid microjunction. Each of the liquid extraction methods use either liquid-
liquid extraction or liquid-solid extraction to desorb analytes from their matrix and the 
electrospray ionization (ESI) mechanism for ionization, however they differ based on the 
method by which the extracted analytes are presented to the ionization event.26 Spray 
desorption methods, the group in which DESI is categorized, use a charged solvent spray 
to first desorb analytes by directing the primary spray towards the sample, creating a thin 
film of the spray solvent on the sample, and continual collisions of the primary spray 
droplets emit charged secondary droplets from the sample surface containing small 
amounts of the extracted analyte. The secondary droplets undergo evaporation and 
coulombic fission generating ions as the secondary and subsequent progeny droplets are 
propelled towards the inlet of the mass spectrometer.27,28 In the substrate spray methods 
desorption and ionization occur directly from the same sample substrate device. The 
substrate typically has a sharp tip and can be used to extra a small amount of material from 
the sample and then by addition of solvent and high voltage, analytes can be desorbed from 
the extracted material and ionized.29,30 The last of the liquid extraction groups is the liquid 
microjunction group of method. These methods use a continuous liquid interface in the 
form of a solvent bridge from a primary capillary or pipet to the sample. Analytes are 
desorbed into the microjunction while being prepared to be ionized for analysis.31,32 
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Spallation of material from a sample occurs by delivering high energy into a small 
area to create shockwaves which cause desorption or ablation of said material. The majority 
of spallation methods use a high energy laser, however other methods have been reported.33 
Typically another technique is then coupled with the spallation process to capture the 
ejected material and ionize the analytes, ESI being the most commonly paired method.34,35 
The last category for ambient ionization techniques described is thermal desorption. 
These are primarily plasma-based methods which use an electrical discharge to desorb and 
ionize analytes. Not all plasma-based methods employ thermal desorption, however it has 
been noted in many cases that the range of detectable species increases when the discharge 
gas is externally heated. Plasmas for these methods have been created by a number of 
means including direct-current, radio frequency glows, coronas, dielectric-barrier 
discharges, microhollow cathode discharges, and microwaves plasmas.36-39 Although many 
small organic species can be detected from surfaces using plasma techniques, they are 
categorized into thermal desorption methods, because the number of species detectable 
greatly increases with the use of an externally heated discharge gas, which many employ. 
This is thought to be due to the increase of molecules into the vapor phase by thermal 
desorption processes. Ionization for these techniques can occur through a number of 
pathways, the five most dominate pathways observed are proton transfer, charge transfer, 
electron capture, ion attachment, and proton/hydride abstraction.25  
 
1.3 DESI-MS Imaging 
DESI, as mentioned above, falls into the ambient ionization category of liquid 
extraction, and more specifically the subcategory of spray desorption. DESI uses two silica 
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capillaries, an inner and an outer, where charged solvent is flowed through the inner 
capillary and a nebulizing gas (i.e. nitrogen) is flowed between the inner and the outer 
capillary. The nebulizing gas helps propel the solvent from the inner capillary to create a 
primary spray of charged droplets from the DESI source.40 The primary spray is directed 
towards a sample surface where the initial collisions of droplets create a thin film of solvent 
on the surface where by liquid-solid extraction analytes are desorbed from the sample and 
into the thin film. The continual bombardment of the thin film with the charged primary 
droplets causes the formation of charged secondary droplets containing the now desorbed 
analytes.41 The secondary droplets subsequently undergo ESI mechanisms and ionize the 
analytes which are introduced to the MS.42 
 DESI has primarily been used as an MS imaging method through the use of a 2-
dimensional moving stage. The DESI source is conventionally held in a stationary position 
with an incident angle of ~35-60o spraying directly at an unmodified sample while the 
moving stage moves the sample at a continuous speed in the x direction. The MS scan time 
and moving stage speed are set to produce a spatial resolution in the x direction of ~150-
250 µm. Each line in the x dimension is separately recorded and spaced in the y dimension 
typically by step sizes identical to the calculated step size to those in the x dimension 
(scanning in x dimension is continuous, but can be calculated using the MS scan time and 
moving stage speed).23  This process of imaging has been used for applications ranging 
from forensic studies such as the detection of counterfeit currency or illicit drug detection 
from latent fingerprints to studies of natural products and their distributions in bacteria 
grown on agar plates.7,43,44 However, some of the most valuable research with DESI-MS 
imaging are related to the diagnosis of disease, and specifically the diagnosis of cancers.  
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The standard method for diagnosis of cancer is histopathological evaluation of tissue 
sections by a histopathologist. The method of diagnosis through histopathology is based 
on morphological and cytological features of tissue sections, such as morphological growth 
pattern, nuclear size and shape, and mitotic index.45,46 These features can be identified 
through the use of histological stains such as hematoxylin and eosin (H&E), but other 
immunohistochemical stains can be used for the identification of specific cancers by 
staining proteins specific to those cancers such as neprilysin for clear cell carcinomas or 
stem cell growth factor receptor (SCFR) for gastrointestinal stromal tumors.47,48 Although 
these methods are the gold standard for diagnosis of cancer, ambiguity in histopathology 
can still occur quite frequently. New methodologies such as DESI imaging can be used to 
support pathological evaluations of suspected diseased tissue using spatially obtained 
molecular profiles. Conventional DESI imaging studies have been performed in negative 
ion mode, where the detection of ions are primarily in the form of [M-H]-. When analyzing 
tissue, M is typically a lipid species which can be generally identified when detected in the 
following m/z ranges 180-350, 350-650, and 650-1000 as a fatty acid, fatty acid dimer, or 
glycerophospholipid species respectively. Depending on the mass analyzer used, the exact 
identification of each ion or lipid detected can be more easily determined. A molecular 
profile is the mass distribution of the detected species and their relative abundance to one 
another in a single mass spectrum. The spatial distribution of molecular profiles can be 
used to classify tissue with certain features (e.g. tissue types), as seen in Figure 1-1 where 
the molecular profile produced from a coronal mouse brain section changes when 
analyzing white brain matter versus grey brain matter. DESI imaging has been successfully 
used for differentiation of cancer and normal disease states in human liver49, bladder50, 
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kidney51, prostate52, testicular53, and brain54,55 tissues. Further evaluation of the molecular 
profiles have been used in particular cases to also distinguish cancer subtypes from one 
another, as is the case with human brain and kidney cancers.51,56 The rich information 
obtained through methods such as DESI imaging has yet to be applied in clinical or surgical 
settings, however the value of this information can be seen through the support by 
clinicians, surgeons, and pathologists who participate in molecular diagnosis research with 
these methods.  
 
1.4 Research Objectives 
The research focus of this dissertation is on advancing the development and 
application of ambient ionization mass spectrometry methodology and technology to the 
biomedical field. This is accomplished by using DESI-MS as the core ambient ionization 
technique for the development and validation of MS libraries containing molecular profiles 
related to tissue disease states. The goal of this research is to use ambient ionization mass 
spectrometry for more accurate diagnosis during intraoperative surgical-guidance and to 
reduce surgical times, which in turn can reduce the risk of infection and complications 
during surgery. Developments during the course of research led to the invention of a new 
ambient ionization technique which was incorporated to the research focus and at times 
used concurrently with DESI-MS for the diagnosis of cancer. 
 Chapter 2 describes the research involved in the development of the novel ambient 
ionization technique, touch spray ambient ionization mass spectrometry. Touch spray (TS) 
uses a small probe (e.g. teasing needle) to pick up negligible amounts material from a 
sample and to transfer the material to the front of a mass spectrometer. The addition of 
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organic solvent extracts analytes from the adsorbed material and the addition of high 
voltage induces ESI-like processes to generate ions via coulombic fission and evaporation 
of the emitted charged droplets. The development of this method as described is for the use 
of tissue analysis for disease diagnosis applications, however this method was also 
explored for applications related to microorganism identification, therapeutic drug 
quantitation, and related small molecule detection.   
 An evaluation of TS for its use as a potential in vivo surgical tool for disease 
screening is described in Chapter 3. This evaluation was performed by concurrently 
studying prostate cancer tissue obtained from surgery with DESI-MS imaging and TS-MS. 
DESI imaging has previously been used to study the molecular differences between tissue 
disease states with great success, however TS capabilities for disease diagnosis had not 
been established. Discussion about fundamental differences and similarities between non-
targeted detection using DESI imaging methodology and targeted single point detection 
using TS methodology is also represented in Chapter 3. These features allowed for DESI 
imaging to first establish the relationship between MS molecular profiles and pathological 
findings which were then targeted using TS. This chapter also includes an assessment of 
TS when used as a non-targeted technique on unknown disease state specimen, 
representing a situation more closely related to its proposed surgical use. 
 Many animal models closely mimic disease characteristics of human cancers such 
as disease progression and disease subtype occurrence as is the case with canine non-
Hodgkin’s lymphoma (NHL). Comparative models can give invaluable information for the 
understanding of specific diseases outside of the studied species, but are also important in 
their own regards. Chapter 4 describes the use of DESI imaging for the analysis of canine 
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NHL and normal tissue with the goal of determining molecular information suitable for 
differentiation of healthy and diseased tissue. Further, molecular patterns for NHL subtypes 
B-cell and T-cell were investigated since disease treatment has been known to differ based 
on tumor subtype in certain cases. Preliminary diagnosis for NHL is typically done through 
an invasive lymph node dissection procedure, however fine needle aspiration (FNA) 
procedures have been used as a less invasive alternative method. FNA procedures are also 
less expensive and more rapid than traditional procedures, but also less reliable since 
diagnosis relies only on cytology (i.e. loss of cellular information in respect to surrounding 
tissue). The last objective described in Chapter 4 is the use of DESI-MS to obtain molecular 
information from FNA samples for comparison to lymph node dissection samples. 
 Evaluation of renal cell carcinoma (RCC) specimen by DESI-MS imaging has 
previously been reported.51 Briefly, 11 paired human papillary RCC specimen and nine 
paired clear cell RCC specimen were evaluated by DESI imaging and processed using a 
supervised multivariate statistical technique. The classification of tumor and normal was 
performed separately for each subtype with averaged classification rates for papillary and 
clear cell RCC of 14.3% and 7.8% respectively. The classification of subtype and normal 
was then performed with an overall averaged classification result of 76.3%. Chapter 5 
discusses an extension of this initial work and includes a higher number of specimen per 
disease state and another subtype, chromophobe RCC. Together, clear cell, papillary, and 
chromophobe RCC represent ~99% of all diagnosed RCC cases.57 The objective described 
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Figure 1-1 Lipid patterns and specific lipid distributions which correlate to different mouse 
brain tissue types. A) Distribution of m/z 834 in a coronal mouse brain section with high 
relative intensities highly correlating to gray matter. B) Representative spectrum from gray 
matter in the mouse brain tissue section. C) Distribution of m/z 888 in a coronal mouse 
brain section with high relative intensities highly correlating to white matter. D) 




CHAPTER 2. TOUCH SPRAY IONIZATION MASS SPECTROMETRY 
2.1 Introduction 
Since the development of DESI-MS in 20041 more than forty ambient ionization 
methods have been described.2-4 As discussed in Chapter 1, these ionization methods can 
be broken into 3 categories based on each methods process of desorption and ionization: 
Liquid extraction, laser ablation, or thermal desorption.5 One of the main characteristics 
consistent among all categories of ambient ionization is the speed of analysis which 
requires a few seconds for the entire process of sampling, ionization, and recording of mass 
spectra. The cause of this feature is the result of eliminating or greatly reducing sample 
pre-treatment, including avoiding separation techniques prior to mass spectrometry. 
Despite avoiding pre-treatment, ambient ionization displays wide applicability combined 
with high sensitivity and high molecular specificity characteristic of mass spectrometry.3,6 
Liquid extraction methods, as described in Chapter 1, are by far the largest group of 
ambient ionization methods and include DESI1, nanospray desorption electrospray 
ionization (nanoDESI)7, liquid microjunction suface-sampling probe (LMJ-SSP)8, probe 
electrospray ionization (PESI)9, and others. Each case can be further broken down into 
their respective subcategory of either spray desorption, substrate spray, or liquid 
microjunction based on their process of desorption. Although the methods listed 
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above may differ by desorption processes, each case uses solvent and high voltage to 
generate the strong electric field needed to produce charged secondary droplets carrying 
dissolved analyte to the mass spectrometer. The charged droplets undergo coulombic 
fission when sufficient surface charge is accumulated as a result of solvent evaporation, 
eventually yielding analyte ions by mechanisms that parallel those in electrospray 
ionization. 
 Substrate spray methods differ from the other liquid extraction methods, because 
desorption and ionization occur from the same sample substrate.5 Included in this family 
of methods is paper spray (PS)10, PESI11, and leaf spray (LS).12 Substrate spray methods 
generate ions from sharp tips, naturally present or created, and require a minute amount of 
sample.  Touch spray (TS) ionization also falls into this family of substrate spray methods, 
using a probe (e.g. teasing needle) to adsorb material from a sample and the use of solvent 
and an electrical potential to desorb analytes and transfer them in ionic form into a mass 
spectrometer by methods discussed above. TS allows for in vivo sampling of material and 
ex vivo analysis once solvent (as needed) and a potential are applied. This method is closely 
related to the metallic probe substrate techniques such as PESI and organic substrate 
techniques such as PS, and characterized by the ability to sample and absorb materials such 
as solid powders, trace amounts of solids on surfaces, solutions, and heterogeneous 
matrices (e.g. tissue) onto a probe. Absorbed material can be transported from the point of 
origin to the MS in two stages, first by physical transfer of a small sample and then by 
transfer of dissolved analytes in the sprayed droplets. TS, as with other spray-based 
ambient ionization methods, allows nearly simultaneous chemical derivatization and 
ionization, generating derivatives that can increase signal and enhance qualitative 
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identification. This chapter describes the methodology of TS and explores applications, 




2.2.1 Biological Tissue Samples 
 
2.2.1.1 Mouse Brain Tissue 
 Mouse brain tissue was acquired from JAX® Mice and Services (Bar Harbor, 
Maine, USA). A mouse brains was sectioned at 15 μm and thaw mounted onto glass 
microscope slides. The slides were stored in closed containers at −20 °C; prior to analysis 
they were allowed to come to room temperature and dried in an electronic desiccator for 
approximately 20 minutes. 
 
2.2.1.2 Human Prostate Tissue 
 Radical prostatectomy specimens were obtained from consented 
patients via Indiana School of Medicine (Indianapolis, IN). Biopsies were obtained using 
a disposable biopsy gun in accordance with an IRB approved protocol. Biopsies were 
frozen, cryosectioned at 15 μm and thaw mounted to glass microscope slides. Sections 
were stored at −80 °C prior to analysis. Histopathology was performed upon H&E staining 




2.2.2 Bacteria Culturing 
 E. coli strains were supplied by bioMérieux, Inc. (Hazelwood, MO) and cultured 
from frozen samples stored at −80 °C in TSAB. Bacteria were cultured on TSA with 5% 
sheep blood (Remel, Lenexa, KS) and incubated in a VWR incubator (Chicago, IL) at 37 





2.2.3.1 Touch Spray Probe 
The TS probe used is a commercially available teasing needle purchased from 
Fisher Scientific (Pittsburgh, PA, USA) while multiple variants also were tested. 
 
2.2.3.2 Chemical and Non-Biological Materials 
The spray solvent used for MS acquisition was methanol, purchased from 
Mallinckrodt Baker Inc. (Phillipsburg, NJ), and applied manually via an adjustable pipette 
(Eppendorf Research-2.5 μL). Additional spray additives including 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) was purchased from 
Sigma-Aldrich (St. Louis, MO). Therapeutic drugs were acquired from Cerilliant (Round 
Rock, Texas, USA). Drugs were stored at −20 °C until diluted in bovine blood to 
appropriate concentrations. Illicit drugs were acquired from Cerilliant (Round Rock, 
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Texas, USA). Drugs were stored at −20 °C until diluted to appropriate concentrations. Non-
organic orange was purchased from national grocer for agrochemical MS experiments. 
 
2.2.4 Instrumentation 
 A LTQ linear ion trap (Thermo Fisher Scientific) was used in experiments unless 
otherwise specified and carried out with the auto gain control (AGC) activated. 
 
2.3 Results and Discussion 
 
2.3.1 Touch Spray Ionization 
 Touch spray ionization is aimed at in vivo sampling and ex vivo analysis of complex 
samples. One specific application envisioned for touch spray is its use as an intraoperative 
tool for rapid diagnosis of tissue disease states to help guide surgical procedures. Analytes 
are transferred from a particular location in the sample to a roughed probe by adsorption. 
Subsequently, solvent and high voltage are used to induce spray ionization processes which 
ionize the analyte and transfer it to the mass spectrometer for analysis. The TS method 
incorporates a user guided method of collecting a MS sample: sampling is remote to the 
mass spectrometer and after material transfer onto a probe, MS is performed directly from 
the sampling device. It is not necessary to use a specific probe material or that it have a 
particular physical form: the transfer of a minute amount of material for MS analysis can 
be achieved by touching, scratching, dipping, swiping, or otherwise attaching sample 
material. The probe is then aligned with the mass spectrometer, high voltage is applied, 
solvent is added, and mass spectra are recorded. In these experiments the touch spray probe 
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was aligned with the atmospheric inlet (2-5 mm away) and an appropriate voltage (4.5 kV) 
was applied to generate a stable electrospray signal without a corona discharge. Solvent 
was either applied manually via pipette (1 μL, which provided mass spectral signals lasting 
only a few seconds) or continuously via a syringe pump (yielding continuous signal until 
analyte exhaustion, typically >1 min). The values listed above gave the most reproducible 
TS results, however stable electrospray conditions were tested and achieved with probe to 
inlet distances of 0.5-20 mm, applied voltages of 3-5 kV, and manual solvent additions of 
0.1-2 μL. 
One suitable probe is a teasing needle (Figure 2-1); these are metallic, possess a 
sharp tip, and are roughened. The metallic and roughened features appear to be beneficial 
when sampling and transferring material, such as biological tissue. The crevasses in the 
roughened surface hold material during sample transfer and analysis, facilitating analyte 
extraction. In addition, in the case of teasing needles, the angled feature was found to 
increase reliability, as it accommodated solvent application and was observed to promote 
solvent flow. Complete wetting of the probe's surface improved extraction of analytes and 
emission of solvent microdroplets, a feature which was not observed in all probes 
evaluated. 
Touch spray is user-guided, placing limits on the rate and reproducibility of 
sampling. It is therefore semi-quantitative with performance dependent on user experience. 
However, it allows ready assessment of the presence or absence of analytes in situ or in 
vivo, information that is critical for applications in fields such as forensics and quality 
control while also providing the ability to monitor relative changes in ion abundances in 
applications such as the diagnosis of disease. 
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2.3.2 Detection of Lipids from Biological Tissue 
 
2.3.2.1 Detection of Lipids from Mouse Brain Tissue 
 The lipid composition of mouse brain tissue has been extensively studied using 
ambient ionization mass spectrometry (e.g. DESI)13 and therefore establishes a biological 
standard by which to qualitatively measure the performance of touch spray ionization. 
Using a light abrasive force and one of the probing methods described above, a small 
amount of biological material from a sample can be adsorbed onto the roughened features 
of the touch spray probe. To measure the TS performance, mouse brain tissue was sampled 
by scratching material in small circular regions (diameter <1 mm) at different points across 
mouse brain tissue sections and at each point the adsorbed material was subsequently 
analyzed by a mass spectrometer. The touch spray mass spectra obtained from a transverse 
mouse brain tissue section displayed in Figure 2-2 are similar to those acquired with DESI, 
where signals in the negative ion mode are dominated by fatty acids (m/z < 300), fatty acid 
dimers (m/z 300–700), and glycerophospholipids (m/z 700–1000). The relative abundances 
of m/z 888.5 (sulfatide 24 : 1), 788.5 (phosphatidylserine 36 : 1), 834.5 (phosphatidylserine 
40 : 6), and 885.5 (phosphatidylinositol 38 : 4) were used to qualitatively assess neural 
composition (white and grey matter) where higher relative abundances of m/z 888.5 and 
788.5 typically correspond to a higher percentage of white matter and higher relatives 
abundances of m/z 834.5 and 885.5 correspond to a higher percentage of grey matter. Touch 
spray was performed at six different positions in a linear path down the line of symmetry 
of the tissue section with the points annotated upon the H&E stain (Figure 2-2). The touch 
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spray mass spectra from the mouse olfactory bulb (Figure 2-2, point 1) displayed unique 
ions detected at m/z 806.5 (PS 38 : 6) and 909.5 (PI 40 : 6) corresponding to parallel 
findings using DESI.13 Similarly, the mass spectra recorded from point 2 indicated a high 
percentage of white matter, corresponding to the corpus callosum. The spectra recorded at 
point 5 show a high percentage of gray matter (periaqueductal gray and/or cerebellum). At 
other points a mixture of gray and white matter was observed with point 3 corresponding 
to the thalamus, point 4 to periaqueductal gray with white matter potentially from the 
posterior commissure, and point 6 primarily white matter from the granular layer of the 
cerebellum with some gray matter. The likeness in the detection of changes in lipid patterns 
by TS-MS to DESI-MS corresponding to different neural compositions in different areas 
of the brain signifies the high level of specificity TS-MS and other ambient techniques 
have when investigating complex matrices.   
The reproducibility of touch spray was assessed using coronal mouse brain 
sections. These sections are comprised of grey and white matter each possessing different 
relative abundances of glycerophospholipids, reflected in the spectra, and whose 
distribution is symmetrical between right and left hemispheres. Touch spray was performed 
at six equally spaced points across one coronal section. Mass spectra were reproducible in 
terms of the prominent glycerophospholipids ions seen and also in terms of their 
approximate relative intensities. They were similar between points of related neural 
composition; for example, A and F indicated grey matter which produces patterns including 
a base peak at m/z 834.5 and major peaks at m/z 788.5 and 885.5 whereas B and E displayed 
an ion m/z 888.5 with a higher ratio of m/z 888.5 to 834.5 than m/z 788.5 or 885.5 to 834.5 
indicating the presence of white matter. 
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2.3.2.2 Detection of Lipids from Prostate Cancer Tissue 
As discussed in Chapter 1, one of the most impactful areas of research with ambient 
ionization is cancer diagnosis and methods such as DESI-MS have been to distinguish 
cancer from normal tissue in human brain and other cancers. However, in the case of brain 
cancer, DESI has also been shown to classify tumor subtypes, grades, and tumor cell 
concentrations.14 As seen in the examples above, TS can obtain specific and reproducible 
spectra from tissue. TS is being applied to prostate cancer to assess malignant and non-
malignant states. The ability to discriminate prostate malignancy from non-malignant 
states is vital for improving the care of patients, and could be furthered by advances in 
molecular-based diagnostics. Prostate cancer tissue from radical prostatectomy specimens 
was evaluated with TS using DESI imaging in conjunction with histopathology to validate 
the TS data. Samples were collected using a disposable biopsy gun and sectioned to allow 
evaluation by histopathology in serial sections (<50 μm). 
DESI and TS spectra acquired from a region of malignant prostate cancer, 
determined by histopathology, are presented in Figure 2-3(A) and (B), respectively. The 
H&E stained biopsy section shown in Figure 2-3(C) is the sample which was analyzed by 
DESI imaging where the area within the black dashed line corresponds to the cancerous 
region identified by pathology. The spectrum presented in Figure 2-3(B) was acquired 
using TS-MS performed on an adjacent section to the DESI imaged tissue section. As 
expected, the glycerophospholipid region (m/z 700–100) was observed to possess many 
similarities between the two methods such as the abundance and ratio of ions at m/z 786.5, 
788.5, 861.5, 863.5, and 885.5 which are tentatively identified as PS(36:2), PS(36:1), 
PI(36:4), PI(36:3), and PI(38:4). The major differences seen between the TS and DESI 
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spectra were the chlorinated phosphotidylcholine adducts present in the TS spectrum at m/z 
values 792.5/794.5, 818.5/820.5, and 844.5/846.5 which are tentatively identified as 
PC(34:2)/ PC(34:1), PC(36:3)/ PC(36:2), and PC(38:4)/ PC(38:3). The chlorinated adducts 
in the TS spectrum indicate a lower salt tolerance in TS than in DESI.15 
 
2.3.3 Detection of Therapeutic and Illicit Drugs 
 
2.3.3.1 Therapeutic Drug Detection and Quantitation 
Therapeutic drug monitoring aids in maintaining drug concentrations within the 
range which is most beneficial to patient health and treatment. Drug concentrations above 
the therapeutic range are often toxic to patients and concentrations below the therapeutic 
range may not have any effect on treatment. Ambient ionization methods such as PS have 
used whole dried blood or whole blood mixed with a coagulant to quantitatively measure 
the concentrations of pharmaceuticals.16 The speed and specificity of ambient methods can 
be directly applied to bedside monitoring of drug concentrations to maintain the most 
effective course of treatments. Whole bovine blood spiked with imatinib, a therapeutic used 
for the treatment of chronic myelogenous leukemia, and with its deuterated isotopomer 
added as internal standard, were analyzed over a range of concentrations. Using the TS 
teasing probe, the whole blood was sampled by dipping once directly into the spiked blood 
to a fixed depth, waiting <1 min to dry after the blood coated the TS probe, and analyzed 
directly after drying for detection of the drug in <2 minutes. Detection was performed in 
full MS mode measuring the total ion count of imatinib to the total ion count of its 
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deuterated isotopomer. The quantitative performance by TS using this methodology was 
similar to that of PS when performed using MS/MS methodology which has been known 
to increase performance and reduce limits of detection.10 TS had a 0.999 linear response 
across the concentration range tested (Figure 2-4). These results could be increased further 
using MS/MS methodology. Furthermore, the percentage error (n = 5) was <10% for 
imatinib concentrations greater than 1 ppm, a value within FDA guidelines (Table 2.1). It 
is envisioned that a modified TS probe may be useful as a semi-quantitative tool that could 
be used as a finger-prick device which could be directly used to measure the concentration 
of therapeutics in whole blood.  
 
2.3.3.2 Illicit Drug Detection 
Forensics, in particular illicit drug analysis, often requires the ability to detect 
compounds in situ from matrices including powders, drug residues on surfaces including 
clothing, and illicit drugs in solution. Mass spectrometry is certainly capable of analyzing 
all of these types of samples when using various types of sample preparation. Touch spray 
offers a rapid method by which to analyze these sample types without lengthy preparative 
steps. TS can be used to probe the needed complex matrix and with the added solvent can 
perform liquid-solid extraction during analysis. For instance, drug residues on clothing 
typically require liquid-solid extraction using bulk solvents prior to analysis whereas with 
TS the material can be lightly rubbed absorbing minute amount of drugs while removing 
negligible amounts of the cloth and the solvent added to the probe can extract the drugs 
during analysis for ionization and detection. This ability was demonstrated by the detection 
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of cocaine from a dried blood spot containing 10 ng of the spiked drug on blue cloth. Drugs 
may often be found in different complex solutions with multiple illicit drugs present, a 
homogenous solution containing 400 ppb each of MDMA, cocaine, and methamphetamine 
was sampled for analysis by dipping the TS probe into the solution and dried at ambient 
temperature (<1 minute). The mass spectrum (Figure 2-5) was recorded by the addition of 
spray solvent and a high voltage; the figure displays ions in the positive ion mode 
at m/z 150.3, 194.3, and 304.3 corresponding to each of the drugs in the solution, 
respectively. 
 
2.3.4 In Vitro Detection of Bacteria 
 Interest in in vitro detection and identification of bacteria by mass spectrometry has 
increased significantly over the past decade.17 This is due to the need for rapid detection 
and identification of pathogens which may cause disease. The ability to directly detect 
biomolecules such as proteins and lipids by matrix assisted laser desorption ionization 
(MALDI)18 and electrospray ionization (ESI), respectively, has reduced diagnosis time 
while improving accuracy due to high molecular specificity. Although these methods have 
been effect, they still require sample pretreatment for analysis which can be time 
consuming and labor intensive. Touch spray was investigated for its applicability to in 
vitro detection with no sample preparation. A minute amount of material, as little as 1% of 
a single bacterial colony, was required for mass spectral analysis. The data presented 
in Figure 2-6 were acquired in the negative ionization mode with automatic gain control 
(AGC) in a burst of signal lasting just a few seconds. Repeated sampling of the E. 
coli culture yielded ionized lipids of identical m/z values and relative spectral intensity, 
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while absolute intensity varied with sampling size. The spectra contained phospholipids in 
a profile from approximately m/z 660–780, including odd-carbon number fatty acid 
phospholipids (e.g. m/z 719.5, phosphatidylglycerol 32:1). It was determined empirically 
that the addition of CHAPS, a surfactant, to the methanol spray solvent increased signal 
and stabilized the TS spectra. Addition of CHAPS at 0.01% was determined to have the 
most beneficial effect without undue interference from the CHAPS chloride adduct 
(m/z 649.8). The observed surfactant effect on improving spectra in ambient ionization due 
to reduction in surface tension is well known.19 
 
2.3.5 Residual Agrochemical Detection on Foodstuff 
 Agrochemical is a general term for chemicals used in agriculture. Agrochemicals 
include a broad range of pesticides used to attract and kill different pests including 
unwanted insects, plants, and fungi. Agrochemicals are directly applied to foods in an 
attempt to prolong crop quality. Many agrochemicals are toxic and pose environmental and 
health risks. Oranges and other citrus fruits are commonly treated (systemically or sprayed 
post-harvest) with fungicides such as thiabendazole, leaving a trace amount of material on 
the surface of the orange peel. Agrochemical levels are monitored and regulated in many 
countries including the United States, typically by chromatographic separation prior to MS 
analysis. This procedure is not readily accomplished in situ, limiting thorough screening of 
foodstuffs; however, fungicides have previously been reported to be readily detected using 
paper spray ionization in situ.20 Similar to the use of ambient ionization in bedside use for 
monitoring therapeutic drugs, the features of TS and other ambient methods may be able 
suitable for the improvement of monitoring of agrochemicals for food safety.  
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A non-organic orange purchased from a national grocer was subjected to analysis 
by TS, in which the probe was used to sample a 4 cm2 area of the peel. The spectrum, 
Figure 2-7, includes ions due to protonated thiabendazole (m/z 202) and imazalil (m/z 297). 
When the method was applied to an organic orange, fungicides were not detected. The 
acquired spectrum matches previously reported fungicides detected from non-organic 
oranges using an alternative ambient ionization method (i.e. low temperature plasma).21 
 
2.3.6 Reactive Touch Spray 
 TS-MS experiments exploiting simultaneous chemical derivatization and 
ionization (i.e. reactive ambient ionization) were explored. Derivatized versions of analytes 
often give greater signals in MS analysis of complex mixtures. The use of appropriate 
reagents allows reduction of complex spectra via analyte signal enhancement or 
characteristic m/z value shifts. Chemical derivatization advantages also extend to detection 
of classes of analytes which may not readily ionize using ambient ionization techniques. 
Reactive touch spray was explored with known types of ambient reactions including non-
covalent adduct formation, (e.g. silver adduction of olefins22) and covalent bond formation 
(e.g. betaine aldehyde with alcohols23). Cholesteryl linoleate and adrenosterone were 
separately sampled and chemically derivatized from unique homogenous solutions using 
the dip sampling method and spray ionization using TS. The unsaturated aliphatic 
functionality of cholesteroyl lineolate reacted with silver nitrate (4 ppm, dissolved in 
acetonitrile) forming non-covalent adducts detected at m/z 755.4 and 757.4 corresponding 
to [cholesteroyl lineolate + 107Ag] and [cholesteroyl lineolate + 109Ag]. Covalent bond 
forming reactions targeting the ketone functional group in adrenosterone, a cholesterol-
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related hormone, were accomplished using Girard's Reagent P and hydroxylamine. The 
detection of cholesterol from bovine blood was accomplished using betaine aldehyde 
which reacts with a poorly ionizable hydroxyl functionality creating a positively-charged 
quaternary amine derivative. It is envisioned that using a combination of chemical 
derivitization techniques could be used to measure total cholesterol levels in blood which 
includes detection of low-density lipoprotein, high-density lipoprotein and triglycerides all 




Touch spray (TS) ionization is a spray-based ambient ionization method capable 
of in situ sampling of complex mixtures. Rapid, reproducible, and specific chemical 
information is obtainable from biological tissue including mouse brain and human prostate 
cancer. Differentiation of specific anatomical regions and disease states based on lipids 
detected in the negative ionization mode appears to be possible. TS-MS of complex 
solutions, including whole blood, could allow for numerous applications in forensics 
(e.g. illicit drug detection) and medicine (e.g. therapeutic drug monitoring). Application in 
the detection of pathogens including bacteria is promising, the detected lipids allowing for 
differentiation of bacteria which may be useful in clinical or environmental settings. Use 
in environmental settings can be expanded to the detection of agrochemicals on foodstuffs 
or the crop bed to reduce human exposure to the toxicity of harmful pesticides. The user-
guided nature of TS allows for the unique sampling abilities while potentially limiting 
absolute quantitation. Further, as is the case for many ambient ionization techniques, 
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simultaneous ionization and chemical derivatization enhances the signal for specific 
analytes or groups of analytes. 
Further development of TS-MS including the sampling methodology, probe design, 
and probe material could lead to improved quantitative performance and reproducibility. 
The ultimate application of the TS technology would be in combination with miniaturized 
mass spectrometer systems to allow for in situ sampling, ionization, and mass analysis. 
The successful detection of lipids from complex biological matrices including 
mouse brain and human prostate cancer tissue and the similarities of those detected lipids 
and patterns to those of established techniques such as DESI provides the basis for further 
investigation of TS-MS as a potential in vivo surgical tool for disease diagnosis. Chapter 3 
will discuss the concurrent study of human prostate cancer with the established technique 
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Table 2.1 Calculated percent errors in the calibration curve for imatinib  
 











Figure 2-1 Methods of sampling different complex matrices such as A) solid matrices 
(tissue) and B) liquid matrices (whole blood). Process of spray ionization shown in C) 
where the orientation of the TS probe to the inlet capillary and the addition of solvent and 





Figure 2-2 H&E stained transverse tissue section of mouse brain displayed in the (top left) 
with annotated positions from the anterior to the posterior of the section. Sampling point 1 
located in the (bottom left) corner displays a representative spectrum obtained from the 
olfactory bulb which contained a unique lipid pattern dissimilar from the other points of 
the brain. Spectra located on the (right) correspond to the annotated points and measure 





Figure 2-3 Spectra taken from adjacent tissue sections of the malignant region of a prostate 
biopsy section with A) corresponding to DESI-MS analysis and B) corresponding to TS-
MS analysis. C) Corresponds to the DESI analyzed biopsy section with pathological 





Figure 2-4 TS-MS calibration curve obtained from repeat analysis (N = 5) of imantinb from 
whole bovine blood in full scan positive ion mode. Data points were obtained from 1 to 
13.3 ppm, error bars correspond to the standard deviation of the 5 repeat analyses, and the 





Figure 2-5 TS-MS of illicit drugs (methamphetamine, MDMA, and cocaine) detected from 
a homogenous solution with each drug at 400 ppb concentrations. Drugs were detected 





Figure 2-6 E. coli. negative ion mode mass spectrum obtained by TS-MS from a sampling 
of <1% of a single colony. Along with the glycerophospholids from the bacteria, the 





Figure 2-7 Positive ion mode mass spectrum of fungicides thiabendazole and imazalil 
detected by TS-MS from wiping a non-organic orange purchased from a nation grocer. 
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CHAPTER 3. DIFFERENTIATION OF PROSTATE CANCER AND NORMAL 
PROSTATE TISSUE BY DESORPTION ELECTROSPRAY IONIZATION 
AND TOUCH SPRAY IONIZATION MASS SPECTROMETRY USING 
RADICAL PROSTATECTOMY SPECIMENS 
3.1 Introduction 
Prostate cancer has been estimated to be diagnosed in the United States over 
233,000 times in 2014, more than any other diagnosed cancer cases.1 Treatments for 
prostate cancer include surgery, radiation therapy, and hormone therapy, the choice 
between them being primarily dependent on the patient's health and the stage of the cancer. 
At the time of diagnosis, over 90% of prostate cancer cases have tumors confined to the 
prostate gland. Before cancer has spread to the outer layer of the prostate, the disease is 
potentially curable through complete surgical resection.2 Standard practice relies on 
preoperative measurements such as rectal examination and clinical biopsy data to guide 
surgical resection. Typically, positive surgical margins are only identified after completion 
of the surgery and have been reported to occur >30%.3 
Needle biopsies are used for early diagnosis of prostate cancer, however this 
method is prone to false negatives, reportedly up to 25%.4 Difficulty in diagnosis from 
needle biopsy is the result of limited sample size, limited number of malignant glands 
among many benign glands, and confusion of benign histological features which mimic 
prostate cancer such as paraganglia or xanthoma. Immunohistochemistry (IHC) is often 
used to label p63, a marker for basal cells, which is present in benign and absent in   
47 
 
cancerous tissue. However, negative staining is not always reliable.5 Currently 
unrepresented in prostate diagnostics is the use of the lipid constituents of tissue, either in 
early diagnosis or in post-surgical tumor margin diagnostics. 
As discussed in Chapters 1 and 2, lipid constituents of tissues are readily detected 
by ambient ionization MS methods such as DESI-MS6 and TS-MS.7 Rapid evaporative 
ionization mass spectrometry or REIMS is a newly developed ambient ionization method 
by Takáts and coworkers used to study lipid constituents from tissues.8 This technique 
analyzes the smoke produced from electrosurgical dissection of tissue by transferring the 
smoke to a mass spectrometer through Teflon tubing using an air jet pump. Currently, the 
method is aimed to use smoke produced during electrosurgical dissection during surgery 
for near-real time tissue identification. Challenges with this method may occur when trying 
to obtain exact pathology on tissue analyzed as the method is extensively destructive. DESI 
and TS, as discussed in previous Chapters, are spray based ambient ionization methods.9 
DESI imaging has been shown to be morphologically compatible, therefore using specific 
solvent systems allows for histopathological evaluations to be performed on the exact 
tissue which has been imaged.10 TS, similar to REIMS, is also a destructive method and 
loses exact pathology information in the exact region analyzed, but TS has been 
demonstrated to give near identical mass spectra to DESI on tissue analyzed from the same 
regions on adjacent tissue sections.   
DESI and TS both produce information rich spectra which are specific and 
reproducible to tissue features, as discussed in Chapters 1 and 2. These qualities, also as 
previously discussed, have been shown to be useful in the detection of molecular patterns 
corresponding to disease which may be useful in pathological evaluations.7 However, the 
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differences between how these methods are performed may make them suitable for 
different tasks. To elaborate, DESI-MS is primarily an imaging technique, allowing 
collection of mass spectra, pixel by pixel, to create 2D molecular images. The collected 
data can be assembled in hyperspectral datacubes11 from which 2D ion images 
corresponding to specific components can be extracted to show the spatial distribution and 
relative amounts of analytes. Applications of DESI in distinguishing diseased and non-
diseased tissue rely on the use of multivariate statistics,11 typically principal component 
analysis (PCA) and linear discriminant analysis (LDA). DESI provides a key connection 
between the information from histopathology and the characteristic mass spectrum that is 
produced for each tissue and disease type because the same (or adjacent) tissue sections 
analyzed by DESI can be evaluated by the pathologist. On the other hand, TS-MS is a user-
guided method in which a spot of interest is directly sampled with a probe, e.g. teasing 
needle, and transferred to the interface of a mass spectrometer, and ionized by the 
application of solvent and high voltage. TS produces information rich spectra which are 
similar to DESI, but in a localized and very rapid process which typically takes a few 
seconds. 
This Chapter explores the potential of DESI-MS and TS-MS for prostate cancer 
differentiation through in vitro analysis of radical prostatectomy specimens. First, DESI-
MS was used to establish the relationship of MS features to pathology and then touch spray 
was used to characterize unknown tissue samples. Training sets for both methods were 
built using data obtained from 12 radical prostatectomy specimens and evaluated by PCA 
and linear discriminant analysis (LDA). Both methods resulted in >95% correct sample 
identification when confirmed against histopathology. A TS-MS evaluation dataset, 
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obtained from another six radical prostatectomy specimens, was used for further 
assessment of the method by taking a non-targeted approach for the MS and statistical 
analysis of the prostate tissue samples. Lastly, the predicted tissue disease states were 




3.2.1 Study Protocols 
 Radical prostatectomy specimens #1–19 were obtained from consented patients 
undergoing treatment at Indiana School of Medicine (Indianapolis, IN) following an IRB 
approved study. Biopsies were obtained from specimens #1–18 after resection using a 
disposable biopsy gun (Max-core disposable core biopsy instrument, Bard Biopsy Systems, 
Tempe, AZ). Biopsies (approximately 4–15 mm × 1 mm × 1 mm) were subsequently 
frozen, cryosectioned at 15 μm, and thaw mounted to glass microscope slides. Sections 
were stored at −80 °C prior to MS analysis. The same slide analyzed by DESI-MS imaging 
was H&E stained and examined by an expert pathologist to identify from tissue 
morphology the presence/absence of prostate cancer. Adjacent sections (separated by 15–
60 μm) were analyzed by TS-MS by sampling areas of 1–4 mm2 from regions of known 
pathology based on the DESI/histopathology assignment of locations as diseased or normal 
tissue. Note that this procedure was necessary because TS is a destructive sampling method 
for thin sections. Radical prostatectomy specimen #19 was inked according to IUSM gross 
pathology protocol then bisected to allow the tissue to be analyzed in vitro. The specimen 
was analyzed by TS-MS at IUSM using an on-site commercial mass spectrometer. No 
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biopsies were taken from specimen #19 and thus no DESI-MS analysis was performed. 
Radical prostatectomy specimen #19 results were compared to gross pathological analysis 
obtained from IUSM. 
A total of 100 samples were prepared from patients # 1–12 and used to create a 
database of tumor and normal tissue mass spectra for both DESI and TS methods. These 
databases are referred to as targeted datasets, because the data used is directly correlated 
with histopathological analysis of the tissue. For the DESI targeted datasets, regions 
outlined as tumor or normal by pathology were selected (4 mm2 on average) and data were 
averaged to create each data point for subsequent multivariate analysis. In parallel, TS was 
performed in the regions outlined as tumor or normal tissue from adjacent tissue sections 
used for DESI and that data was directly used to create the TS targeted dataset. Table 
3.1 shows in detail the number of sections prepared per biopsy and patient. Another 70 
biopsies were prepared from the other 6 radical prostatectomy specimens (patients # 13–
18) and these were analyzed only by TS-MS to create an evaluation dataset to further test 
performance. Table 3.2 details the section or sample number and then the relation to patient 
and biopsy. The biopsy sections used to create this independent evaluation dataset were 
randomly chosen and sampled 1–2 times (depending on the size of the tissue) to create a 
110 sample dataset. Also included in the evaluation set were 1–2 randomly selected 
samples from each patient used in the targeted dataset. Histopathology of these tissue 






3.2.2 Ambient Ionization Techniques 
 
3.2.2.1 DESI-MS 
A laboratory-built DESI ion source, similar to the commercial 2D source from 
Prosolia, Inc. (Indianapolis, IN, USA) was coupled to a linear ion trap mass spectrometer 
(LTQ) controlled by XCalibur 2.0 software (ThermoFisher Scientific, Waltham, MA) and 
used in DESI experiments. The negative ionization mode was used with the automatic gain 
control (AGC) inactivated. The spray solvent used for DESI-MS was dimethylformamide 
(DMF)–acetonitrile (ACN) at a 1:1 ratio (v/v), both solvents were purchased from 
Mallinckrodt Baker Inc. (Phillipsburg, NJ), and delivered at 1.0 μL min−1 flow rate using 
the instrument syringe pump. The DESI source parameters were set as follows: capillary 
temperature 275 °C, voltage applied to the stainless steel needle syringe 5 kV, capillary 
voltage −25 V, tube lens voltage −115 V, capillary incident angle 54°, spray to surface 
distance 3 mm, sample to inlet distance 5 mm, and nitrogen gas at 180 PSI. Prostate tissue 
sections were analyzed using a moving stage with a lateral scan rate of 303.03 μm s−1 in 
horizontal rows separated by a 200 μm vertical step. Instrument scan time was coordinated 
with scan speed providing 200 × 200 μm pixels. DESI spot size approximately 350-500 
μm. Full scan mass spectra were acquired in negative ion mode in the mass range m/z 200–
1000. For statistical analysis of the evaluation dataset, a reduced mass range of 700–1000 





The TS probe used was a commercially available teasing needle purchased from 
Fisher Scientific (Pittsburgh, PA, USA).7 Methanol (Mallinckrodt Baker Inc., Phillipsburg, 
NJ) was used as spray solvent and 1 μL was applied manually via an adjustable pipette 
(Eppendorf Research-2.5 μL). The LTQ linear ion trap mass spectrometer was also used 
for the TS experiments with the same operating parameters as those used in the DESI 
experiments except that the voltage applied to the TS probe was 4 kV and the automatic 
gain control was active. TS was performed by touching and desorbing material onto a 
teasing needle from regions of interest of 1–4 mm2. After sampling, the tip of the probe 
was directed at the inlet of the mass spectrometer and the high voltage and 1 μL of solvent 
were applied. The extracted analytes were analyzed in a spray time of 6 seconds. The data 
acquired within this period were averaged to represent a single data point. 
 
3.2.3 Multivariate Statistical Methods 
 
3.2.3.1 Principal Component Analysis 
An in-house program was used to convert the MS data files (.raw) into ASCII files 
(.txt), which were imported into Matlab (MathWorks, Inc., Natick, USA). Biomap software 
(http://www.maldi-msi.org) was used to display single ion images (i.e. spatial distribution 
of a single m/z variable, Figure 3-1) with MS intensity represented in false color 
(normalized to the absolute value). For each DESI image, information was coded as a 
datacube (X·Y·MS), where “X” and “Y” are spatial dimensions and the “MS” domain 
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contains the m/z variables and corresponding intensity (i.e. an entire mass spectrum). 
Groupings of adjacent pixels,i.e. regions-of-interest (ROIs), representing areas of tumor or 
normal tissue were selected in the 2D spatial domain (X·Y), according to pathological 
evaluations, and the corresponding mass spectra were averaged. The averaged mass spectra 
from the prostate sections constituted the DESI target dataset. The TS target dataset was 
built using a list of m/z values and ion abundances from the average mass spectrum (over 6 
s of data acquisition) acquired per sample. The data were then imported into Matlab. 
 The acquisition step used to increment m/z values was equal to 0.0833, therefore 
the two data matrices (DESI and TS) consisted of 3601 columns (i.e. m/z values) and 100 
rows (i.e. samples: normal tissue sections, n = 74; tumor tissue sections, n = 26). PCA was 
performed with in-house Matlab routines. PCA is commonly used for exploring complex 
information contained within mass spectral datasets, allowing consideration of all spectral 
variables and possible inter-correlations simultaneously.11,12 By means of PCA, the 
information of the original m/z variables is reorganized and compacted in a few principal 
components (PCs). That is, PCA can be used as an unsupervised data compression 
technique. When dealing with high-dimensional data, the compression of the relevant 
information is a preliminary step in order to efficiently manage and extract useful features. 
All MS spectra were normalized by the standard normal variate (SNV) transform, 
correcting for both baseline shifts and global intensity variations,13,14 and then column 
centered. The principal components are orthogonal (i.e. uncorrelated) and efficiently 
describe large fractions of the information. The projections of the data objects onto the PCs 
are called scores, while the importance of each original variable in defining a certain PC is 
given by a loading coefficient. Groupings in the score plot indicate similarities among the 
54 
 
objects (i.e. samples), based on the information derived from the mass spectra. Both scores 
and loading values were represented in two-dimensional scatter plots. 
 
3.2.3.2 Linear Discriminant Analysis 
Linear discriminant analysis (LDA) was performed as a supervised discriminant 
classification technique. Discriminant methods look for a delimiter that divides the global 
domain into a number of regions, each assigned to one of the classes.15,16 This delimiter 
identifies an open region for each class and such regions determine the assignment of the 
samples to one of the classes. Model validation (i.e. evaluation of the predictive ability of 
the model) was performed by means of cross validation (CV).16 For this study, five cross-
validation deletion groups were selected, meaning that all the samples (n = 100) were 
divided five times systematically in a training set (objects used for building the 
classification model, n = 80) and a test set (remaining objects used to evaluate the 
predictive ability of the model, n = 20), with all the samples being in the test set only once. 
Eventually, the final model was built using all the objects. LDA was applied on the DESI 
and TS target datasets of SNV normalized mass spectra after compression by PCA, thereby 
using as variables the principal components (instead of the original mass spectral data). 
Two classes were modelled: normal tissue (n = 74) and tumor (n = 26). In more detail, 8 
PCs for DESI and 9 PCs for TS were computed each time with the training samples and 
used for building the classification model. The test sets – samples that did not contribute 
in the model building process – were used to estimate the global prediction rate for all 
classes, hence as the CV prediction rate for each class. This is a so-called complete 
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validation strategy.16 The CV prediction rate is the percentage of correct predictions on the 
objects in the CV test sets. The CV confusion matrix shows how many samples belonging 
to a certain category were correctly/incorrectly assigned by the classification rule to that 
category. Indeed, in this matrix, each element gives the number of samples of the row 
category assigned to the column category. When the matrix is diagonal (entries outside the 
main diagonal are all zero) there is a perfect prediction of all the samples. Note that LDA 
models used for supervised discriminant classification were built by using 4 to 10 PCs. The 
models with 8 and 9 PCs, for DESI and TS respectively, were chosen as they provided the 
least number of false results (i.e. highest prediction rates) in cross-validation. 
The model built for the TS dataset was used further to predict the normal/disease 
state of another 110 samples (the evaluation set), whose histopathology was unknown at 
the time of MS analysis. The subsequent comparison between molecular diagnosis by TS-
MS and histological diagnosis further validated the TS-MS model performances. LDA was 
performed with Matlab using in-house routines. 
 
3.2.3.3 Canonical Correlation Analysis 
Canonical correlation analysis (CCA) is a way of measuring the linear relationship 
between two multidimensional variables (DESI and TS) observed on the same sample 
collection.17,18 In this study, the two datasets represent the DESI and TS mass spectra 
recorded from 100 prostate tissue sections. The DESI mass spectral dataset is considered 
as a reference. CCA rotates the original variables in the two blocks, to obtain some pairs 
of variables (one for each block), called canonical variables, with maximum correlation 
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between the two blocks. The dimensionality of these new bases is equal to or less than the 
smallest dimensionality of the two sets of variables. The canonical variables are linear 
combinations of the original autoscaled (i.e. unitary variance) variables, whose 
contribution in defining a specific canonical variable can be inferred through the 
corresponding loading value. The correlation coefficients between the DESI canonical 
variable and the corresponding TS canonical variable are termed canonical correlation 
coefficients. Specific details on CCA can be found elsewhere.17,18 In order to overcome the 
high inter-correlations across m/z values, CCA was performed after PCA, which acts as an 
unsupervised data compression technique. Two separate PCAs were run on the SNV 
normalized and column-centered DESI and TS mass spectral data. The first 10 PCs, 
explaining about 90% of total data variation, were selected and used for CCA. CCA was 
performed by the free chemometric package V-PARVUS 2010 (University of Genova, 
Italy, (http://www.csita.unige.it/software/free/other.html). 
 
3.3 Results and Discussion 
 
3.3.1 DESI and TS Lipid Patterns and Training Sets 
Prostate cancer is a heterogeneous disease diagnosed by histopathology. Diagnosis 
is based on morphological variations which are a result from underlying biochemical 
changes. The two main criteria used by histopathologists for diagnosis are atypical 
architectural features (e.g. perineural infiltration) and atypical cytological features 
(e.g. enlarged nuclei). Typical diagnosis of prostate cancer uses these features and IHC 
staining of specific proteins, but does not currently use the lipid constituents of the tissue. 
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In this study, two different ionization techniques, DESI and TS, were used to acquire lipid 
profiles of prostate cancer and normal tissue and subsequently those profiles were used to 
differentiate the two different disease states of the tissue.  
The lipid constituents which were used to investigate disease state are primarily 
glycerophospholipids: phosphotidylethanolamines (PhE), phosphotidylserines (PhS), 
phosphotidylcholines (PhC), and phosphatidylinositols (PhI). These lipids can be observed 
in the average normal (74 samples) and tumor (26 samples) mass spectra shown in Figure 
3-2 for DESI (A and B) and TS (C and D). Differences between the lipid profiles of prostate 
cancer and normal tissue are subtle. Many small changes in relative ion intensities of 
specific ions and a few completely different lipid constituents are seen with small ion 
intensities can be seen when comparing the spectra of different disease states. Most of the 
same changes between prostate cancer and normal tissue are seen in both DESI and TS 
spectra. These changes include ratio changes for ions m/z 788 and 885, an increase in 
relative abundance of ions m/z 786, 835, 861, 863, and a decrease in relative abundance of 
ions such as m/z 737. Despite similarities between TS and DESI methodology and spectra, 
there are also differences in their average mass spectra (Figure 3-2A vs. D, Figure 3-2B vs. 
E). For example, chlorinated adducts of phosphatidylcholine species (e.g. m/z 794) are 
more abundant in the TS spectra than in the DESI spectra. Some of these chlorinated 
adducted species, like m/z 794, are also useful in differentiation of prostate cancer and 
normal tissue. The addition of the chlorinated adducts in the TS spectra suggests that some 
differences between the ionization methods can be attributed to different salt content 
tolerances, which has been previously reported.19 The spectra from Figure 3-2 also displays 
other information that reflects differences between TS and DESI, average ion intensity in 
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TS is two orders of magnitude greater than that in DESI, suggesting that 
extraction/desorption occurs more rapidly in comparison to DESI. Considering all of the 
lipid profiles recorded for the entire training dataset, 12 patients and 100 samples 
(thousands of mass spectra), the differences between disease states are difficult to address 
by eye. Therefore, a robust statistical strategy is needed to efficiently explore the chemical 
information contained in the mass spectra. PCA was performed as an unsupervised 
exploratory tool to identify chemical features that characterize prostate cancer and normal 
tissue based on the DESI and TS lipid profiles corresponding to those disease states. 2-
dimensional PCA score plots are shown in Figure 3-3A and B for DESI and TS, 
respectively. Both 2D plots display the lowest-order principal components (PCs) for which 
separation between normal and tumor tissue is apparent, however separation occurs 
multidimensional. Distinct separation and groupings of normal (dark green objects) and 
tumor tissue samples (red objects) can be observed from these plots. The 2D loading plots 
shown in Figure 3-4A and B display those lipids that contribute the most to each PC. 
The first principal component by definition encompasses the largest variation in the 
multidimensional space of the original variables, PC2 is orthogonal and includes the largest 
remaining variation, and the same is true for PC3 and on until all variation is accounted 
for. The separation seen in PC space between prostate cancer and normal tissue is due to 
the reproducible differences between their DESI (and TS) mass spectra (i.e. lipid profiles 
specific to disease state). The TS spectra are usually more complex than the DESI spectra, 
which may be attributed to inherent differences in the recorded spectra (e.g. chlorinated 
adducts of PhC species). Due to the noisier spectra, the best separation among red and dark 
green objects in PCA space for TS is in the PC3 vs. PC4 score plot or 19.6% of the variance. 
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By contrast, DESI mass spectra result from averaging many pixels in the hyperspectral 
images, selected as regions of interest (prostate cancer or normal tissue) and this helps 
reduce random noise. In DESI, the best separation is along PC2 vs. PC3 or 22.8% of the 
variance. The additional complexity in the TS spectra adds additional complexity to PCA, 
resulting in TS score plots having lower total variation of the data explaining the separation 
of prostate cancer and normal tissue than DESI does. 
The loading plots which correspond to the best separation of disease states for DESI 
and TS also display a similar relationship between the variables (m/z values) that contribute 
to either the diseased state or healthy state. This observation provides initial insight into 
the consistency between DESI and TS in recovering the same biochemical features 
associated with a disease state. Variables consistent between both methods based on 
statistical examination are ions m/z 835, 861, 885, and 887 which higher in relative 
abundance in prostate cancer tissue and m/z 788 which is higher in relative abundance in 
normal prostate tissue. 
 
3.3.2 Classification of Prostate Cancer and Normal Tissue using Lipid Profiles 
 LDA was performed on the DESI and TS targeted datasets (selected data which 
correlated to identified tumor or normal samples by histopathology) to quantify the PCA 
separation between prostate cancer and normal samples. The first eight and nine PCs were 
used for DESI and TS datasets, respectively, which correlated to ~90% of the total variance 
of each dataset (this provided the highest prediction rates for both prostate cancer and 
normal classes by reducing the additional noise that makes up the last ~10 of total 
variance). The average cross-validation (CV) prediction rate was 98% for DESI and 96% 
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for TS. The CV confusion matrices, Table 3.3, report the number of false results per class 
(prostate cancer and normal) obtained through the cross-validation process. DESI performs 
slightly better than TS-MS, which is expected due to the reduction of noise by averaging 
of many more spectra as discussed above, although both methods exceed 95% in correct 
predictions. 
 TS-MS is envisioned to be used as previously discussed in Chapters 1 and 2 as an 
intraoperative tool to help surgeons rapidly determine disease state information. To test the 
potential performance of TS-MS, an additional evaluation set was tested using a non-
targeted approach, mimicking a true surgical setting. Samples were acquired from patients 
#13–18 and a total number of 70 biopsies were performed from which 110 samples were 
analyzed randomly, prior to any pathological evaluation. The PCA-LDA model built on 
the targeted TS dataset was used to predict the tissue condition (tumor or normal) of these 
unknown samples. The LDA predictions, based on MS molecular diagnosis, were finally 
compared with pathological evaluation of adjacent tissue sections to those analyzed. 
Pathology diagnosed nine samples as prostate cancer and the remaining 101 samples were 
diagnosed as normal tissue. The PCA-LDA results were only moderately discriminatory 
which we attribute to the low reproducibility of some ions (e.g. chloride adducts) and the 
effect of this reproducibility as well as complication from ions which do not contribute to 
any disease state when applied to PCA analysis. We therefore built a supervised LDA 
model using the top five discriminant ions in the range m/z 700–1000, as opposed to 
compressing the entire mass spectra by PCA, using a stepwise variable selection strategy 
to select the most discriminant ions.15 This strategy proved more efficient and robust in 
differentiating tumor and normal tissue for the TS targeted dataset. Table 3.4 displays the 
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results of the supervised method, with no prediction errors in cross validation. Moreover, 
the average percentage of correct prediction of tumor and normal tissue for the external 
evaluation set (110 samples) was equal to 93%. It should be noted that the small number 
of samples with tumor tissue was due to the non-targeted selection of the samples analyzed 
and that because one of the nine prostate cancer samples was misclassified the entire 
predication rate for both classes suffered. The overall prediction rate for the normal 
samples was 96% and it is expected that an increase in numbers of prostate cancer non-
targeted samples would increase the overall prediction rate to a higher percentage, similar 
to that of the normal prediction rate. The improvement in statistical evaluation from an 
unsupervised method to a supervised method suggests that further refinements of the 
strategy used for data analysis could strengthen a decision-making strategy based on 
molecular diagnosis. A wide portfolio of pretreatment processes and variable selection 
techniques is available for pattern recognition analysis, following the needs of the acquired 
MS data structures. 
 
3.3.3 DESI and TS: Similarities and Outlook 
 Since DESI imaging records spectra in pixels across all of an imaged area, it can 
be used to directly correlate lipid profiles to pathology and MS analysis can be performed 
before prior to pathology. TS on the other hand investigates a single point, thus TS needs 
some information prior to being performed (e.g. pathology on adjacent tissue when 
building a library or a previously built TS-MS library to be used for disease prediction). 
Thus, similarities between DESI and TS mass spectra in providing chemical features 
associated with a healthy or diseased state is of interest, because DESI can then be 
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performed and used as a basis for subsequent TS analysis on adjacent tissue. Although 
based on similar mechanisms of ion generation (i.e. electrospray-like mechanisms), DESI 
and TS have been shown above to produce mass spectral features with some similarities 
and some differences, but key features to disease states seem to be consistent. Since 
diagnosis capabilities seem to be similar from the targeted datasets, the differences in how 
the techniques are performed may determine the techniques to be used in their own fit-for-
purpose strategies for molecular diagnosis.  
To estimate the similarities or correlation between the two sets of targeted MS data, 
canonical correlation analysis (CCA) was performed for DESI and TS. Figure 3-5 shows 
the samples in the canonical variable space (1 vs. 2) for DESI and TS with a clear separation 
between prostate cancer (red) and normal tissue samples (dark green). The correlation 
coefficients for the first three canonical variables are 0.94, 0.76, and 0.68 respectively 
(Figure 3-6). The high correlation between DESI and TS is also supported by the location 
of each data point (labelled with the same data point number corresponding to specific 
samples in both plots) in the CCA space. For example, prostate cancer data point number 
98 can be seen in the far left middle region of both plots and the normal data point number 
74 can be seen in the bottom right corner region of both plots. The loading plots (Figure 3-
7) show the greatest contribution to the canonical variable computation from principal 
components 1, 2, and 3 for DESI and principal components 2, 3, and 4 for TS. The 
differences between the PCs which correlate to the canonical variable computation for 
DESI and TS is due to the fact that the principal components that carry the biochemical 
information relevant to separating tumor and normal tissue samples are 1, 2, and 3 for 
DESI, but 2, 3, and 4 for TS. 
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The CCA results suggest that the chemical features present in DESI and TS spectral 
patterns which correlate to prostate cancer and normal tissue are consistent between 
methods. These results suggest that both methods will have similar diagnostic performance, 
but with different, possibly complementary, diagnostic implementations based on the how 
the technique is performed as now discussed. Some of the most important features of TS 
is its use of the probe as a means of a user guided sampling tool and as the tool which 
serves as the source where a spray is induced to produce ions for mass spectral analysis. 
TS has been previously reported to produce spectra from a variety of samples and is not 
limited to tissue sections, but can be used to investigate areas of interest in vivo.7,20 Figure 
3-8 shows the degree of similarity of (A) a TS mass spectrum obtained by sampling a 
bisected radical prostatectomy specimen in vitro and (B) a TS mass spectrum obtained 
from a frozen tissue section from the training set. TS is an extremely rapid technique, where 
the total time from initial sampling to final data collection can be within 20 seconds or 
longer depending on the transfer time step where the sample could be directly next to the 
mass spectrometer or in another room, building, etc. DESI imaging on the other hand is 
only performed on tissue sections or thin films of tissue material such as tissue smears21 
and allows for collection of mass spectra, pixel by pixel, to create 2D molecular images. 
Single 2D ion images can be made from assembled hyperspectral datacubes containing the 
2D spatial information with a third dimension of each mass spectrum. The 2D ion images 
correspond to specific m/z components and can be extracted to show the spatial distribution 
and relative amounts that analyte. 
Limited sample size is the main disadvantage of TS-MS. The minimal removal of 
material from a sensitive source such as tissue is viewed as an advantage for the patient, 
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but it limits the power of the technique by reducing analysis to a few MS scans before the 
signal is exhausted. This could be overcome by multiple examination of the same area, but 
each additional sampling requires more time. The limited sample size collected by the TS 
probe also forces the user to carefully consider the measurement uncertainty due to 
sampling, which may bias the analytical results. Time may be the main disadvantage for 
DESI imaging. Time is required for the minimal sample preparation to produce tissue 
sections or smears and is required for each pixel taken within an image. Higher spatial 
resolution for images and higher mass resolution for mass spectra can make MS images 
take hours, but depending on the number of pixels and mass resolution needed some images 
can be performed in minutes. 
Due to the TS-MS features and performance, this technique is envisioned as a 
surgical tool for disease screening of areas of interest. As a surgical screening tool, TS 
could help preserve healthy tissue that may have otherwise been resected for 
histopathological evaluation or help with decisions to remove additional diseased tissue 
that was observed to be questionable. DESI imaging features and performance make this 
technique to be envisioned for use as a supplemental and orthogonally complementary 
technique for pathological evaluation of tissue sections. This could help with absolute 
pathology on tissue and provide understanding not only of morphological changes, but of 
the underlying biochemical changes which may explain the morphological changes. DESI 
is also being further developed outside of imaging methodologies and may also play a role 





 DESI-MS and TS-MS have been used to successfully differentiate prostate cancer 
and normal tissue using biopsies taken from 18 radical prostatectomy surgical specimens. 
The targeted datasets (radical prostatectomy specimen 1–12) were subjected to 
discriminant classification analysis using PCA-LDA. Average prediction rates of 97.5% 
for DESI-MS and 96% for TS-MS were obtained using this type of unsupervised statistical 
analysis. The validation of TS-MS as a non-targeted technique which may be used in a 
surgical setting was performed using an external evaluation set (radical prostatectomy 
specimen 13–18) of unknown disease states of prostate specimens. These unknown 
specimens were randomly surveyed using TS-MS and the non-targeted data sets were 
analyzed using supervised statistical methods which provided average predictions rates of 
92.5%, though this percentage is thought to be improved with a larger dataset, specifically 
prostate cancer samples. DESI and TS results are comparable (0.94 correlation coefficient 
by CCA), recovering similar biochemical information, primarily glycerophospholipids, 
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Table 3.1 Samples for DESI and TS targeted datasets 
Patient # Biopsy # Sample # DESI:TS Diagnosis Gleason Scorea 
1 6 2:8 Tumor (3+4)7 
2 3 6:3 Tumor (3+4)7 
2 2 3:6 Normal (3+4)7 
3 9 5:6 Tumor (4+3)7 
3 7 6:3 Normal (4+3)7 
4 3 6:4 Tumor (4+3)7 
4 6 6:3 Tumor (4+3)7 
4 9 5:7 Tumor (4+3)7 
4 7 2:4 Normal (4+3)7 
5 1 3:1 Normal (4+5)9 
5 2 5:3 Normal (4+5)9 
5 3 5:4 Normal (4+5)9 
5 4 7:4 Normal (4+5)9 
5 5 3:4 Normal (4+5)9 
5 6 5:3 Tumor (4+5)9 
5 7 6:3 Normal (4+5)9 
5 8 2:7 Normal (4+5)9 
5 9 5:4 Normal (4+5)9 
6 1 5:2 Normal (4+3)7 
6 2 5:3 Tumor (4+3)7 
6 3 7:3 Normal (4+3)7 
6 4 4:7 Tumor (4+3)7 
6 5 4:6 Normal (4+3)7 
6 6 3:7 Tumor (4+3)7 
6 7 7:8 Tumor (4+3)7 
6 8 8:6 Tumor (4+3)7 
6 9 7:4 Tumor (4+3)7 
6 10 5:4 Tumor (4+3)7 
7 5 6:7 Normal (4+3)7 
7 6 3:4 Normal (4+3)7 
7 7 4:5 Normal (4+3)7 
7 8 4:5 Normal (4+3)7 
7 10 3:4 Normal (4+3)7 
7 12 5:4 Tumor (4+3)7 
7 14 3:4 Normal (4+3)7 
8 2 6:5 Normal (3+4)7 
8 3 5:6 Normal (3+4)7 




Table 3.1, Continued 
Patient # Biopsy # Sample # DESI:TS Diagnosis Gleason Scorea 
8 5 3:4 Normal (3+4)7 
8 6 5:6 Tumor (3+4)7 
8 7 7:6 Normal (3+4)7 
8 8 5:4 Normal (3+4)7 
8 9 7:6 Tumor (3+4)7 
8 10 5:4 Tumor (3+4)7 
8 11 3:4 Normal (3+4)7 
8 12 7:6 Normal (3+4)7 
8 13 6:5 Normal (3+4)7 
8 15 4:6 Normal (3+4)7 
9 3 4:5 Normal (3+4)7 
9 7 6:7 Normal (3+4)7 
9 8 6:5 Normal (3+4)7 
9 10 5:4 Normal (3+4)7 
9 13 6:7 Normal (3+4)7 
9 14 3:2 Normal (3+4)7 
9 15 6:5 Normal (3+4)7 
9 17 3:4 Tumor (3+4)7 
10 1 7:6 Normal (4+3)7 
10 2 5:6 Normal (4+3)7 
10 3 6:5 Normal (4+3)7 
10 4 4:3 Normal (4+3)7 
10 5 6:7 Tumor (4+3)7 
10 6 4:5 Normal (4+3)7 
10 8 6:7 Normal (4+3)7 
10 9 4:5 Normal (4+3)7 
10 10 6:5 Normal (4+3)7 
10 11 6:7 Normal (4+3)7 
10 12 5:6 Normal (4+3)7 
10 13 7:6 Normal (4+3)7 
10 14 4:3 Normal (4+3)7 
10 16 6:7 Normal (4+3)7 
11 1 5:4 Normal (4+5)9 
11 2 4:5 Normal (4+5)9 
11 3 5:6 Normal (4+5)9 
11 4 6:5 Normal (4+5)9 
11 5 7:5 Tumor (4+5)9 
11 7 6:5 Tumor (4+5)9 
11 8 5:4 Normal (4+5)9 
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Table 3.1, Continued 
Patient # Biopsy # Sample # DESI:TS Diagnosis Gleason Scorea 
11 9 4:5 Tumor (4+5)9 
11 10 5:4 Tumor (4+5)9 
11 11 5:6 Normal (4+5)9 
11 12 4:5 Normal (4+5)9 
11 13 5:4 Normal (4+5)9 
11 15 5:4 Normal (4+5)9 
11 16 5:4 Normal (4+5)9 
11 17 3:4 Normal (4+5)9 
11 18 3:4 Normal (4+5)9 
11 20 3:4 Tumor (4+5)9 
11 21 4:3 Normal (4+5)9 
11 22 6:5 Normal (4+5)9 
11 23 6:5 Tumor (4+5)9 
11 24 3:4 Normal (4+5)9 
11 25 3:4 Normal (4+5)9 
11 27 3:4 Normal (4+5)9 
12 2 5:4 Normal (4+3)7 
12 7 5:6 Normal (4+3)7 
12 8 4:5 Normal (4+3)7 
12 9 6:5 Normal (4+3)7 
12 10 4:3 Normal (4+3)7 
12 13 2:3 Normal (4+3)7 
12 15 4:3 Normal (4+3)7 
 




Table 3.2 Samples for TS evaluation set 
Patient # Biopsy # Sample # TS Diagnosis Gleason Scorea 
1 6 4 Tumor (3+4)7 
1 8 1 Normal (3+4)7 
2 3 1 Tumor (3+4)7 
2 3 1 Normal (3+4)7 
2 2 1 Normal (3+4)7 
3 9 3 Normal (4+3)7 
3 7 2 Normal (4+3)7 
3 7 2 Normal (4+3)7 
4 6 1 Normal (4+3)7 
4 6 1 Tumor (4+3)7 
4 7 5 Normal (4+3)7 
4 7 5 Normal (4+3)7 
5 6 5 Tumor (4+5)9 
6 6 1 Tumor (4+3)7 
6 3 2 Normal (4+3)7 
6 3 2 Normal (4+3)7 
7 10 5 Normal (4+3)7 
7 12 2 Normal (4+3)7 
7 12 2 Tumor (4+3)7 
8 9 4 Normal (3+4)7 
8 9 4 Tumor (3+4)7 
8 15 3 Normal (3+4)7 
8 15 3 Normal (3+4)7 
9 15 4 Normal (3+4)7 
9 15 4 Normal (3+4)7 
9 17 5 Normal (3+4)7 
10 11 4 Normal (4+3)7 
11 5 3 Normal (4+5)9 
11 23 3 Normal (4+5)9 
11 23 3 Normal (4+5)9 
12 14 4 Normal (4+3)7 
13 9 5 Normal (3+4)7 
13 11 2 Normal (3+4)7 
13 14 3 Normal (3+4)7 
13 18 3 Normal (3+4)7 
14 2 5 Normal (4+3)7 
14 2 5 Normal (4+3)7 




Table 3.2, Continued 
Patient # Biopsy # Sample # TS Diagnosis Gleason Scorea 
14 4 3 Normal (4+3)7 
14 4 3 Normal (4+3)7 
14 5 4 Normal (4+3)7 
14 6 4 Normal (4+3)7 
14 8 5 Normal (4+3)7 
14 8 5 Normal (4+3)7 
14 10 5 Normal (4+3)7 
14 10 5 Normal (4+3)7 
14 12 5 Normal (4+3)7 
14 12 5 Normal (4+3)7 
14 14 3 Normal (4+3)7 
15 2 5 Normal (3+4)7 
15 3 4 Normal (3+4)7 
15 3 4 Normal (3+4)7 
15 8 5 Normal (3+4)7 
15 8 5 Normal (3+4)7 
15 10 3 Normal (3+4)7 
15 10 3 Normal (3+4)7 
15 11 5 Normal (3+4)7 
15 12 5 Normal (3+4)7 
15 13 4 Normal (3+4)7 
15 14 5 Normal (3+4)7 
15 14 5 Normal (3+4)7 
15 15 4 Normal (3+4)7 
15 15 4 Normal (3+4)7 
16 7 6 Normal (4+3)7 
16 7 6 Normal (4+3)7 
16 10 5 Normal (4+3)7 
16 11 4 Normal (4+3)7 
16 11 4 Normal (4+3)7 
16 12 4 Normal (4+3)7 
16 12 4 Normal (4+3)7 
16 14 3 Normal (4+3)7 
16 14 3 Normal (4+3)7 
16 15 3 Normal (4+3)7 
16 15 3 Normal (4+3)7 
16 16 2 Normal (4+3)7 




Table 3.2, Continued 
Patient # Biopsy # Sample # TS Diagnosis Gleason Scorea 
17 1 6 Normal (3+4)7 
17 1 6 Normal (3+4)7 
17 2 5 Normal (3+4)7 
17 4 5 Normal (3+4)7 
17 4 5 Normal (3+4)7 
17 5 4 Normal (3+4)7 
17 5 4 Normal (3+4)7 
17 6 5 Normal (3+4)7 
17 6 5 Normal (3+4)7 
17 7 3 Normal (3+4)7 
17 7 3 Normal (3+4)7 
17 8 3 Normal (3+4)7 
17 8 3 Normal (3+4)7 
17 9 4 Normal (3+4)7 
17 9 4 Normal (3+4)7 
17 10 6 Normal (3+4)7 
17 10 6 Normal (3+4)7 
17 12 4 Normal (3+4)7 
17 13 5 Normal (3+4)7 
17 13 5 Normal (3+4)7 
17 15 4 Normal (3+4)7 
17 15 4 Normal (3+4)7 
18 3 4 Tumor (5+4)9 
18 4 2 Normal (5+4)9 
18 7 4 Normal (5+4)9 
18 7 4 Normal (5+4)9 
18 10 4 Normal (5+4)9 
18 10 4 Normal (5+4)9 
18 11 3 Normal (5+4)9 
18 11 3 Tumor (5+4)9 
18 12 5 Normal (5+4)9 
18 13 4 Normal (5+4)9 
18 16 4 Normal (5+4)9 
18 16 4 Normal (5+4)9 
 




Table 3.3 PCA-LDA cross-validation results for DESI and TS targeted datasets 
(A) DESI-MS CV prediction rates (C) TS-MS CV prediction rates 
Normal 98.7% Normal 96.1% 
Tumor 96.2% Tumor 95.8% 
Average 97.5% Average 96% 
(B) DESI-MS CV confusion matrix (D) TS-MS CV confusion matrix 
Species Normal Tumor Species Normal Tumor 
Normal 73 1 Normal 73 3 





Table 3.4 Stepwise-LDA validation results for TS targeted and non-targeted datasets 
(A) TS-MS stepwise LDA on the 
targeted dataset 
(C) TS-MS non-targeted prediction rates 
Normal 100% Normal 96% 
Tumor 100% Tumor 89% 
Average 100% Average 92.5% 
(B) TS-MS stepwise LDA targeted 
confusion matrix 
(D) TS-MS non-targeted confusion 
matrix 
Species Normal Tumor Species Normal Tumor 
Normal 74 0 Normal 97 4 






Figure 3-1 DESI-MS ion images displaying relative distributions of ions m/z 788, 885, 786, 
835, 861, and 883. Ions correlating to prostate cancer based on PCA (i.e. m/z 786, 835, 
861, and 883) have high relative abundances in the middle of the ion images unlike ions 
with no correlation to disease state (i.e. m/z 788 and 885) which have high relative 






Figure 3-2 (A) Average targeted DESI-MS of normal prostate tissue samples (N = 74). (B) 
Average targeted DESI-MS of prostate cancer tissue samples (N = 26). (C) Prostate tissue 
biopsy example with black dashed outlined region of cancerous tissue diagnosed by 
histopathology, tissue section example was imaged by DESI-MS. (D) Average targeted 
TS-MS of normal prostate tissue samples (N = 74). (E) Average targeted TS-MS of prostate 
cancer tissue samples (N = 26). (F) Adjacent prostate tissue biopsy to the DESI example 
analyzed by TS-MS, again the cancerous region diagnosed by histopathology is outlined 






Figure 3-3 (A) DESI-MS PCA score plot, PC2 vs. PC3, displaying separation of prostate 
cancer (red objects) and normal prostate tissue samples (dark green objects). (B) TS-MS 
PCA score plot, PC3 vs. PC4, displaying separation of prostate cancer (red objects) and 




Figure 3-4 (A) DESI-MS PCA loading plot, PC2 vs. PC3, displaying ions which contribute 
to the separation of prostate cancer and normal prostate tissue samples in the corresponding 
PCA score plot. (B) TS-MS PCA loading plot, PC3 vs. PC4, displaying ions which 
contribute to the separation of prostate cancer and normal prostate tissue samples in the 





Figure 3-5 (A) Canonical variable 1 vs. 2 score plot displaying separation of prostate cancer 
(red objects) and normal tissue samples (dark green objects) for DESI-MS targeted dataset. 
(B) Canonical variable 1 vs. 2 score plot displaying separation of prostate cancer (red 





Figure 3-6 CCA correlation plot between DESI (X) and TS (Y) with the first 3 correlation 






Figure 3-7 (A) CCA loading plot displaying greatest canonical variable contribution from 
the DESI principal components which correlate to biochemical information related to 
healthy and diseased states. (B) CCA loading plot displaying greatest canonical variable 
contribution from the TS principal components which correlate to biochemical information 






Figure 3-8 (A) TS-MS obtained in vitro from radical prostatectomy case 19, lipid pattern 
suggests sampled area was obtained from a region of prostate cancer and this agrees with 
gross pathology findings. (B) TS-MS obtained from a targeted prostate cancer sample from 
the TS training set. Similarities, especially those related to lipids correlating to prostate 




CHAPTER 4. DESORPTION ELECTROSPRAY IONIZATION – MASS 
SPECTROMETRY DIFFERENTIATION OF CANINE NON-HODGKIN’S 
LYMPHOMA FROM NORMAL LYMPH NODE TISSUE USING SURGICAL 
TISSUES AND FINE NEEDLE ASPIRATE SMEARS 
4.1 Introduction 
Non-Hodgkin’s lymphoma (NHL) is a large diverse group of cancers of 
lymphocytes or white blood cells. NHL is the 7th most common human cancer in the U.S. 
resulting in an estimated 20,000 deaths in 2014.1 Canine lymphoma is currently being 
considered as a meaningful comparative model for human NHL, while important in its own 
right.2,3 Some comparative modes, like canine lymphoma, closely mimic disease 
characteristics such as rates of occurrence, subtype occurrence, disease progression, and 
prognosis to that of the human disease characteristics. Diagnosis of NHL is acquired 
through histopathological evaluation of the surgically removed suspect lymph node (whole 
or in part). Histopathological diagnosis is based on morphological and cytological features, 
such as morphological growth pattern, nuclear size and shape, and mitotic index.4,5 Fine 
needle aspirate (FNA) biopsy is a less invasive alternative diagnosing method to surgical 
resection of tissue. FNA is performed using a hypodermic needle that is inserted into a 
suspicious lymph node to remove a small amount of cellular material. The cellular material 
removed is simply expelled onto a microscope slide, and smeared to form a thin cellular 
layer which then is evaluated using light microscopy following cytochemical or 
immunocytochemical staining. Challenges with diagnosing using this method occur due to
86 
 
smaller sample size and lack of morphological information which can result in higher 
rates of false negatives and inconclusive diagnoses.6 Aside from the advantages of being 
a less invasive method, FNA procedures are also less expensive and less technically 
demanding to perform.7,8 Thus, identifying methods to enhance the quality of diagnostic 
information afforded by FNA would be worthwhile. 
 Desorption electrospray ionization – mass spectrometry (DESI-MS) has been 
discussed in the previous Chapters as an ambient ionization technique that investigates the 
chemical profiles of surfaces, including tissue, at native atmospheric conditions 
(temperature, pressure, and humidity).9 As discussed previously, DESI-MS imaging has 
been applied to studying lipid profiles of human brain10, kidney11, liver12, and prostate13 
cancers as well as canine bladder14 cancer and others15,16 for potential use in surgical and 
clinical settings. The DESI-MS data is used by multivariate statistic methods for pattern 
recognition, such as principal component analysis (PCA) followed by supervised 
classification techniques (like linear discriminant analysis, LDA), for visualization and 
classification of differences between the samples and potentially complex relationships 
(e.g. tumor subtype, grade, or cell concentration) within large datasets. 
 In this Chapter, canine lymphoma surgical tissue sections and FNA smears are 
explored by DESI-MS for disease state and further subtype differentiation. DESI-MS 
imaging of the surgical tissue sections allowed for direct correlation of lipid profiles to 
specific disease state regions confirmed by histopathology. This initial work establishes a 
relationship of indicative biochemical information to disease states with which to compare 
lipid profiles obtained from FNA smears. FNA analyzed by ambient ionization - mass 
spectrometry has previously neither been demonstrated to be of diagnostic use nor shown 
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to yield similar information to that of the primary tissue from which it was obtained. The 
characteristic lipid profiles obtained from surgically resected lymph nodes and FNAs are 
certainly complementary, and potentially an alternative, to invasive procedures in 
combination with histopathology and less reliable diagnosis in combination with cytology. 
Comparison between previous data regarding the significant lipids in human NHL and this 





 Specimens were provided by the College of Veterinary Medicine, Purdue 
University. All NHL specimens were collected from pet dogs presented to the Purdue 
University Veterinary Teaching Hospital (PUVTH) for medical treatment of their cancer. 
At the time of presentation, fine needle aspirate samples were collected from an affected 
lymph node in each dog using a 22 gauge hypodermic needle.  FNA samples were expelled 
onto glass slides, allowed to air dry, and then stored at -80oC until the time of DESI-MS 
analysis. Immediately following FNA, all dogs with NHL underwent surgical resection of 
the same affected peripheral lymph node. A portion of each resected tissue was fixed in 
10% neutral buffered formalin and submitted for histopathologic confirmation of NHL. 
The residual portion of each dog’s resected lymph node tissue was snap frozen in liquid 
nitrogen, and the samples were stored at -80oC until the time of DESI-MS analysis. Lymph 
node samples from healthy, purpose-bred research dogs served as normal controls. All 
control animals had been humanely euthanatized as part of an academic laboratory course 
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within the Purdue College of Veterinary Medicine Doctor of Veterinary Medicine degree 
curriculum. Surgical lymph node tissue and FNA samples of peripheral lymph nodes were 
collected immediately post-mortem from all control animals in identical fashion to that 
described for pet dogs with NHL. All lymph nodes from control animals were confirmed 
to be histologically normal following light microscopic review of H&E stained sections 
from formalin-fixed tissues by a board-certified veterinary pathologist (JAR). All medical 
and surgical procedures conducted on both control animals and pet dogs were approved by 
the Purdue Animal Care and Use Committee. The number of canine specimens analyzed is 
indicated in Table 4.1 by sample diagnosis and type (i.e. surgical tissue or FNA). 
 
4.2.2 DESI-MS Analysis 
 Frozen surgical tissue specimens were cryosectioned at 15 μm thickness using a 
Cryotome FSE (Thermo, Waltham, MA, USA) and thaw mounted on glass microscope 
slides (Gold Seal Rite-On Microscope Slides, Thermo). Prior to analysis, the slides were 
allowed to come to room temperature and briefly dried using an electronic desiccator 
(VWR, Desi-Vac Container, Radnor, PA, USA) for approximately 10 minutes to remove 
any frozen condensation resulting from storage. FNA smears were also dried for ~10 
minutes prior to analysis, for the same reason, and analyzed under the same conditions. 
Normal and tumor samples were randomized over multiple days of analysis, surgical tissue 
sections and specimen matched FNA were analyzed on the same day. DESI-MS was 
performed using a lab built prototype ionization source coupled to a linear ion trap mass 
spectrometer (LTQ, Thermo). DESI-MS was carried out in the negative ion mode using 
equal parts dimethylformamide (DMF) and acetonitrile (ACN), preserving tissue 
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morphology and allowing subsequent histopathology to be performed on the analyzed 
tissue section. DESI analysis was performed using the following major parameters: 
automatic gain control (AGC) off, 5 kV spray voltage, 180 PSI N2(gas), incident spray angle 
was 52˚, capillary temperature of 275°C, spray-to-surface distance ~2 mm, and spray-to-
MS inlet distance ~8 mm. Sample slides were analyzed by securing them to a moving stage. 
The MS scan rate was coordinated with the moving stage speed in the “x” dimension (i.e. 
rows), defining resolution (200 μm). Upon the completion of each row, the moving stage 
was stepped vertically in 200 μm increments defining the “y” resolution. 
 
4.2.3 Pathology 
 Histopathologic review, with tumor subtyping according to World Health 
Organization criteria, was performed on formalin-fixed lymph node tissue sections as part 
of routine clinical diagnosis. The clinical diagnosis was used for DESI-MS data correlation. 
Samples thought to contain heterogeneous morphological features were evaluated post 
DESI-MS analysis and annotated by histopathologic review of frozen tissue sections. There 
were no cases in which histopathology review differed between frozen and formalin-fixed 
tissue sections. The annotated regions were used to define areas associated with non-




4.2.4 Data Analysis 
 
4.2.4.1 DESI-MS Ion Images 
Surgical tissue and FNA smear data acquired using XCalibur 2.0 (.raw) were 
converted with an in-house program into files compatible with BioMap software 
(http://www.maldi-msi.org). BioMap was used to generate 2D ion images (retaining spatial 
relationships and displaying relative mass spectral abundance of particular mass-to-charge 
ratios), select regions of interest (ROI) based on pathology, and export data for multivariate 
analysis. An in-house MatLab (MathWorks, Inc., Natick, MA, USA) routine was used to 
explore chemical features present in two dimensional DESI ion images. PCA was 
performed upon each spatial pixel (and corresponding mass spectrum) and plotted using 
an interactive brushing procedure. An interactive brushing procedure was performed, 
connecting object grouping in PCA space to similarity in chemical information and spatial 
location (i.e. pixels).17 Objects are manually selected from the score plot and visualized in 
a 2D image - pixels associated with the selected region are colored coded. This allowed 
heterogeneous samples to be manually investigated, correlating histopathology and 
chemical composition. 
 
4.2.4.2 Multivariate Analysis of Surgical Tissues 
Multivariate analysis was performed using in-house MatLab routines. PCA was 
used to explore DESI-MS data and visualize the grouping of samples resulting from 
chemical similarity.18 The mass range was truncated (m/z 700-1000) for statistics, as it was 
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empirically found to contain less analytical variability, providing more consistent and clear 
separation with regards to disease state (i.e. normal vs. tumor). Two specimens were 
excluded from statistics: one lymphoma sample (due to poor MS signal) and a metastatic 
carcinoma.  MS data were normalized by the total ion current (TIC) and column-centered 
(i.e. mean-centered). LDA was performed for discriminant classification after 
unsupervised data compression by PCA (i.e. PCA-LDA), as reported elsewhere.19 The first 
8 principal components (PCs), accounting for ~90% of total data variation, were used. 
Cross validation (CV) with 5 deletion groups was used to test the prediction ability in 
classifying samples. 
 
4.2.4.3 Multivariate Analysis of FNAs 
Average DESI mass spectra obtained from FNA smears were compared with those 
of surgical tissue via multivariate statistics. Direct comparison of FNA smear mass spectra 
with a database built on mass spectra from surgical tissue sections was performed by 
overlaying FNA samples onto the PCA score space (PC2 vs. PC5 score plot) defined by 
the surgical tissue samples. The FNA smear data matrix (SNV normalized) was mean-
centered with the centroid (i.e. the row vector containing the mean values of each m/z 
variable) of the surgical tissue data matrix (SNV normalized). Multiplication of the FNA 
centered data with the loading matrix defined for the surgical tissue samples yielded a PCA 
score matrix for the FNA samples. Surgical and FNA score values for PC2 and PC5 were 
overlaid in the same score space. Further, FNA data were classified using a PCA-LDA 
classification method developed with surgical tissue section data. 
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4.3 Results and Discussion 
 
4.3.1 DESI Imaging of Surgical Tissue 
 DESI-MS analysis of surgical tissue aims to explore and establish the lipid profiles 
indicative of normal and NHL tissue and further NHL tumor subtypes. Negative mode 
DESI mass spectra showed ionized fatty acids (e.g. oleic acid, m/z 281), fatty acid dimers, 
and glycerophospholipids from m/z 700-1000 (e.g. PI(38:4), m/z 885). The major 
glycerophospholipids (GPL) ions observed included: phosphatidylinositols (PI), 
phosphatidylserines (PS), phosphatidylethanolamines (PE), and phosphatidylglycerols 
(PG). The majority of lymphoma containing tissue sections displayed a conserved lipid 
profile that contrasted normal tissue, and varied more slightly between B-cell and T-cell 
subtypes. 
 Some differences in the chemical information within an analyzed tissue section 
were noted for a few of the normal and tumor specimens. In all of these cases (with the 
exception of cases with mixed disease states) the difference in chemical information 
resulted from the presence of perinodal adipose tissue, as determined by post hoc 
histopathology. Specimen 31 is illustrative, Figure 4-1B, a surgical tissue section 
comprised primarily of a B-cell tumor with smaller regions of non-neoplastic, perinodal 
adipose tissue. The lipid profile is homogenous throughout the tumor regions; however, 
the small regions corresponding to perinodal adipose tissue (outlined) are show 
significantly different lipid profiles and overall lower absolute signal intensity as seen in 
each ion image (particularly m/z 281.5).  The chemical difference of this region was further 
explored using PCA and an interactive brushing procedure, see Figure 4-2. The PCA score 
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plot, displaying each pixel from the DESI image, of specimen 31 indicated three groups 
within the tissue section: B-cell lymphoma associated pixels (red selection), perinodal 
adipose associated pixels (green selection), and background associated pixels (black). The 
results of visual interpretation and PCA of the MS images correlated well with the 
pathological assessment, considering the differences in spatial resolution of MS imaging 
and histopathology. Perinodal adipose tissue was also detected in some of the normal 
lymph node cases, for example specimen 42, as shown in Figure 4-1C. The difference in 
the lipid profile was again evident between the two regions with GPL signal only abundant 
in the lymph node parenchyma. The low GPL signal in adipose tissue is likely correlated 
to adipocytes (i.e. fat cells), which typically have a large cytoplasmic volume to GPL 
membrane surface area ratio. Adipocytes also contain greater levels of triglycerides and 
cholesteryl esters which are not readily detected in the negative mode with the solvent 
conditions chosen. However, detection of such compounds in positive ion mode from 
biological material has been reported with the addition of silver nitrate to the solvent 
reservoir.20,21 
 
4.3.2 Data Analysis of DESI Evaluated Surgical Tissue 
 The lipid profile of surgical tissues was statistically explored (qualitatively and 
quantitatively) for molecular-based differentiation of disease state (normal versus tumor) 
and tumor subtype (i.e. B-cell lymphoma versus T-cell lymphoma). The average DESI 
mass spectrum (from m/z 700-1000) of all normal lymph node, B-cell lymphoma, and T-
cell lymphoma tissue sections, green, blue, and gold respectively, are displayed in Figure 
4-3A-C. Overall, the lipid profiles of the three cases look distinctly different from each 
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other. The ratios of m/z 788.3 to 838.5 to 885.5 were found to differ between normal, B-
cell, and T-cell samples. The average spectra obtained from lymphoma specimens 
contained less abundant peaks that differed in abundance from normal samples including 
m/z 747.4, 773.3, 786.4, 812.4, 883.5. The lipids that were altered in lymphoma and their 
relative changes mirror those reported previously by Eberlin et al. in murine and human 
specimens.22   
 The hierarchy of diagnosis starts with the differentiation of the disease state, normal 
or tumor. PCA showed grouping of normal lymph node (green) and tumor (red) samples, 
Figure 4-3D. Dispersion of the tumor samples in the PCA score plot, compared with the 
normal samples, is indicative of greater chemical heterogeneity. NHL subtyping has two 
major divisions, B-cell and T-cell, correlated to the lymphocyte immunophenotypes from 
which the cancer originated. The dispersion of the lymphoma samples might be related to 
the tumor subtype, Figure 4-3E, normal (green), B-cell lymphoma (blue), and T-cell 
lymphoma (gold) samples. The PCA loading plot, displayed in Figure 4-3F, aided in 
understanding which lipids from m/z 700-1000 contributed most to PC2 and PC6 
computation (see Figure 4-4). Visual comparison of this information to the average spectra 
of each class (i.e. normal, B-cell, or T-cell) supports the basis of the PCA separation. 
Distinguishing NHL subtypes represents another level in the hierarchy of diagnosis and is 
typical performed by a combination of standard histopathology and more extensive 
immunohistopathology. Separation of B-cell and T-cell lymphoma is suggested in Figure 
4-3E; however, upon removal of the normal samples from PCA, separation of B-cell and 
T-cell tumor subtypes is more apparent (Figure 4-5). This example represents a potential 
hierarchy of molecular diagnosis, similar to that of histopathology, where differentiation 
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of disease state (i.e. tumor or normal) is first obtained based on an entire library of spectra 
according to the disease and then more specific information may be investigated using a 
smaller population of the library for better diagnosing (e.g. tumor subtype from the tumor 
library). The ability to subtype tumors using DESI-MS has been previously demonstrated, 
e.g. brain and kidney tumors.10,11 However, lymphoma subtyping has not been reported. 
 The quantitative performance of the PCA results from the DESI-MS data in 
determining disease state and subsequently tumor subtype from surgical tissue sections was 
performed using a discriminant classification model created using PCA-LDA. Cross-
validation was performed using five deletion groups resulting in an average prediction 
classification rate of 96%, Table 4.2a, for disease state (i.e. normal versus tumor). 
Differentiation of tumor subtype was also successful with an average predicted 
classification rate of 96%, Table 4.3a. The predicted classification of T-cell lymphoma 
(85.7%) was relatively poor in comparison to the other states (normal, 96% and B-cell 
lymphoma, 100%), likely the result of a smaller sample size (n=7). 
 
4.3.3 DESI Imaging of FNA 
 FNA smears, prepared using standard protocols, were analyzed without any 
additional sample pre-treatment. It was assumed that aspiration and subsequent smearing, 
was sufficiently homogenizing. Therefore, DESI imaging was performed on a small area 
of the smear, representing a time reducing strategy for preliminary diagnosis. The MS data 
obtained from FNA samples were very reminiscent of surgical tissue sections. 
Representative specimen matched surgical tissue and FNA samples are displayed in Figure 
4-6. The surgical tissue section of specimen 18 and the corresponding FNA smear 
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possessed nearly identical lipid profiles, characteristic of B-cell lymphoma. Similarly, 
specimen 38, appeared normal in both the surgical tissue section and the FNA smear, note 
the characteristic ratio of ions m/z 788, m/z 838, and m/z 885. 
 FNA smears were nearly always chemically homogenous supporting the 
assumption of sufficient homogenization, however changes in the total signal intensity 
were common (Figure 4-7A).  The presence of blood in some smears, smear visually red 
in coloration, caused distinct changes in the lipid profile obtained. The presence of blood 
contamination significantly increased one particular lipid, m/z 810, which corresponds to 
PS(40:6) a major membrane constituent of erythrocytes.23 Minor blood contamination did 
not seem to cause a significant change to the lipid profile. Two major variables in FNA 
samples were found to affect total signal intensity: the quantity of cellular material 
aspirated and the degree of dilution due to smearing. The effect of quantity is seen in Figure 
4-7B in which the heterogeneity present in the ion image results from variable amount of 
material – signal intensity is correlated with material quantity. The degree of smearing of 
the aspirated sample or diluting of the cellular material is necessary for current cytology in 
which isolated cells are desirable, while undesirable for chemical analysis by DESI-MS 
where limits of detection may come into question, although single cell analysis has been 
previously reported. Slight modification to current FNA smear protocols that compensate 





4.3.4 Data Analysis of DESI Evaluated FNA 
 The chemical information obtained from FNA smears by DESI imaging was 
evaluated by multivariate statistics to determine diagnostic performance as well as to 
explore how translatable the chemical information obtained from surgical tissue sections 
is to FNA smears. Diagnostic performance was qualitatively explored by projecting FNA 
samples onto the PCA score space of the matched surgical tissue samples, displayed in 
Figure 4-8. The clinical information relevant to screening and preliminary diagnosis is the 
identification of tumor. Visually, the separation and grouping of normal and tumor 
samples, Figure 4-8A and 4-8B respectively, is mostly consistent with the matched surgical 
tissue samples. Multiple regions were analyzed from a select number of tumor FNA 
samples (specimen 8, 13, and 19) that appeared spatially heterogeneous, hence the 29 
tumor points in Figure 4-8. The regional points from these specimens grouped tightly and 
correctly in the tumor region, suggesting the appeared heterogeneity is simply due to total 
signal heterogeneity. This supports previous discussion of mass spectral chemical 
homogeneity and the need for slight modifications to the FNA smear protocol for DESI-
MS. 
 The quantitative diagnostic performance was evaluated by testing the FNA smear 
data against the classification training set built from surgical tissue samples data. The PCA-
LDA classification results are displayed in Table 4.4a. The overall predicted classification 
rate of normal and tumor FNA samples was 87.5% with 4 false negative and 1 false 
positive. Although classification results are slightly worse than that predicted in cross-
validation of the surgical tissue, the results support that the chemical information relevant 
to disease state is equivalently detected in the surgical tissue and FNA by DESI-MS. FNA 
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smears are known to be less reliable than surgical tissue samples evaluated by 
histopathology and are neither adapted nor optimized for MS analysis. 
As is the case with molecular diagnosis of NHL using surgical tissue by DESI-MS, 
the alternative envisioned application of molecular diagnosis of NHL using FNA smears 
would also include the ability of tumor subtyping. PCA cross-validation of surgical tissue 
indicated the possibly for tumor subtyping (average predicted classification rate of 96%) 
which is further explored using FNA smears. PCA-LDA was performed as above, 
developing a classification training set using the surgical tissue samples for evaluation of 
the FNA samples (predicting disease state). The overall average predicted classification 
rate, displayed in Table 4.5a, was 76.2% with 2 false negatives, 1 false positive, and 1 
tumor subtype misclassification. The overall prediction rate was greatly lowered by the 
poor classification rate of the T-cell lymphoma subtype (50% correctly predicted 
classification rate). This low classification rate is likely due to both the low number of 
initial T-cell surgical tissue specimens used in training set (n=7 and surgical tissue CV rate 
of 85.7%) and the even lower number of T-cell FNA samples (n=4) of which to be 
evaluated against the training set. However, the B-cell FNA samples which had a much 
larger surgical tissue training set (n=27) and FNA test set (n=27) had a predicted 
classification rate of 93%. The results indicate that tumor subtyping is probable while only 
conclusions concerning classes with sufficient sample numbers (normal and B-cell NHL) 
can be drawn. It is expected that extension of this method to include a more diverse and 
abundant population of samples will result in an overall higher predicted classification rate. 
Overall, the primary goal of FNA analysis by DESI was demonstrated, rapid molecular-
based differentiation of normal and tumor specimens, which has promise as a 
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complimentary method to cytology and could significantly enhancement the rapid 
diagnosis of lymphoma. 
 
4.4 Conclusions 
 Differences in the lipid profile, acquired by DESI-MS, allowed differentiation of 
normal lymph node and NHL tumors from surgical tissue and FNA smears. Normal lymph 
node tissue was chemically homogenous while differences in absolute signal were noted 
between normal lymph node anatomy, e.g. medulla and cortex. Tumor samples were 
generally homogenous, particularly B-cell NHL samples matching known tumor growth. 
Some normal lymph node and tumor samples contained perinodal adipose which typically 
had an absence of signal, likely due to the conditions of the experiment. Multivariate 
statistics allowed for qualitative and quantitative differentiation of normal and tumor 
surgical tissue samples, the latter yielding a predicted classification rate of 96%. Further, 
subtyping of the surgical NHL tumor tissues was possible with an equal predicted 
classification rate. 
 FNA smears, previously unexplored for diagnosis using ambient ionization – mass 
spectrometry, provided the same chemical information relevant to disease state 
differentiation as the surgical tissues. Multivariate analysis of the FNA smears yielded an 
average classification rate of 87.5% for normal vs. tumor and 76.2% for NHL subtypes 
when using the classification method built from the surgical tissue data. DESI-MS signal 
was dependent on the smear composition (e.g. blood contamination), aspirated material 
quantity, and the dilution factor of the material by smearing. Changes in the FNA protocol 
to tailor for MS analysis is likely to improve results. 
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 DESI-MS imaging of surgical tissues provided a means of exploring and 
establishing the lipid profiles indicative of normal lymph node and NHL subtypes. The 
process of FNA and smearing loses histological information such as the tissues 
morphology, however the biochemical information related to those changes is still easily 
detected by DESI-MS. Tumor subtype prevalence, clinical behavior, and chemical changes 
in GPL all emulate that of human NHL, which supports the development and use of canine 
comparative models. The methodology outlined in this Chapter is novel and applicable to 
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Sample Included in 
Statistics Comments 
Surgical Tissue FNA 
1 T-zone lymphoma x     
2 Diffuse large B-cell lymphoma x x   
3 Diffuse large B-cell lymphoma x x   
4 Peripheral T-cell lymphoma x x   
5 T-zone lymphoma x x   
6 B-cell lymphoma, tonsil x x   
7 T-cell lymphoma x     
8 Diffuse large B-cell lymphoma x x 5 FNA ROIs 
9 Diffuse large B-cell lymphoma x x   
10 Diffuse large B-cell lymphoma x x   
11 Diffuse large B-cell lymphoma x x   
12 Metastatic carcinoma     Excluded 
13 Diffuse large B-cell lymphoma x x 4 FNA ROIs 
14 T-zone lymphoma x     
15 Diffuse large B-cell lymphoma x x   
16 Diffuse large B-cell lymphoma x x   
17 Diffuse large B-cell lymphoma x x   
18 Diffuse large B-cell lymphoma x x   
19 Diffuse large B-cell lymphoma x x 4 FNA ROIs 
20 Diffuse B-cell lymphoma x     
21 Diffuse large B-cell lymphoma x     
22 Diffuse large B-cell lymphoma x x   
23 Diffuse large B-cell lymphoma     Excluded (MS signal) 
24 Diffuse large B-cell lymphoma x     
25 Peripheral T-cell lymphoma x x   
26 Diffuse large B-cell lymphoma x x   
27 Peripheral T-cell lymphoma x x   
28 Diffuse large B-cell lymphoma x     
29 Diffuse large B-cell lymphoma x x   
30 Diffuse large B-cell lymphoma x x   
31 Diffuse large B-cell lymphoma x     
32 Normal x     
33 Normal x     
34 Normal x     
35 Normal x x 2 FNA ROIs 
36 Normal x     
37 Normal x     
38 Normal x x   
39 Normal x     
40 Normal x     
41 Normal x     
42 Normal x x   
43 Normal x     
44 Normal x     








Sample Included in 
Statistics Comments 
Surgical Tissue FNA 
46 Normal x     
47 Normal x     
48 Normal x x   
49 Normal x x   
50 Normal x     
51 Normal x x   
52 Normal x     





Table 4.2 Surgical Tissue Classification Rate and Confusion Matrix Information for Tumor 
and Normal Disease States 
 




(b) Surgical Tissue Confusion Matrix 
Species Normal Tumor 
Normal 22 2 





Table 4.3 Surgical Tissue Classification Rate and Confusion Matrix Information for Tumor 
Subtype and Normal Disease States 
 





(b) Surgical Tissue Confusion Matrix 
Species Normal B-cell T-cell 
Normal 22 0 1 
B-cell 0 27 0 





Table 4.4 FNA Classification Rate and Confusion Matrix Information for Tumor and 
Normal Disease States 
 




(b) FNA Confusion Matrix 
Species Normal Tumor 
Normal 6 1 





Table 4.5 FNA Classification Rate and Confusion Matrix Information for Tumor Subtype 
and Normal Disease States 
 





(b) FNA Confusion Matrix 
Species Normal B-cell T-cell 
Normal 6 0 1 
B-cell 1 26 0 






Figure 4-1 Negative mode DESI-MS ion images displaying the distribution of ions m/z 
281.5, 747.5, 788.4, 838.5, and 885.6 and the corresponding H&E stain for (A) a B-cell 
lymphoma sample (Specimen 18) in regards to chemical and spatial homogeneity, (B) a B-
cell lymphoma sample (Specimen 31), containing small regions of perinodal adipose 
(outlined), and (C) an illustrative normal sample (Specimen 42) displaying a large region 
of perinodal adipose (outlined) which was chemically different than that of the normal 






Figure 4-2 (Left) H&E stain of specimen 31 with annotated non-neoplastic regions in 
green. (Middle) DESI-MS pixel image with each pixel of the false color indicating 
similarities in their chemical profile. (Right) PCA score plot of all pixels (i.e. MS) within 
the DESI-MS pixel image with the grouping selected related to the false color represented 






Figure 4-3 Average negative ion mode DESI mass spectrum of surgical tissue for (A) 
normal lymph node (n=22), (B) B-cell lymphoma (n=27), and (C) T-cell lymphoma (n=7). 
(D) PCA score plot of normal (green) and NHL (red) samples. (E) PCA score plot of 
normal (green), B-cell lymphoma (blue), and T-cell lymphoma (gold) samples. (F) PCA 












Figure 4-5 (Left) PCA score plot for B-cell and T-cell lymphoma, gold and blue 






Figure 4-6 Negative ion mode DESI-MS of (A) B-cell lymphoma (Specimen 18) obtained 
from a surgical tissue section and (B) its matched FNA. Negative ion mode DESI-MS of 
(A) normal lymph node tissue (Specimen 38) obtained from a surgical tissue section and 






Figure 4-7 Negative mode DESI ion images corresponding to m/z 747, 788, 812, 838, and 







Figure 4-8 (A) PCA of FNA normal lymph node samples (black diamonds) overlaid upon 
score plot from the classification of surgical tissue, normal surgical tissue samples (green 
circles) and NHL surgical tissue samples (red circles). (B) PCA overlay of FNA NHL 
samples (black diamonds) on the same surgical tissue score plot described above. 
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CHAPTER 5. DIFFERENTIATION OF CLEAR CELL, PAPILLARY, AND 
CHROMOPHOBE RENAL CELL CARCINOMA SUBTYPES BY DESORPTION 
ELECTROSPRAY IONIZATION – MASS SPECTROMETRY 
5.1 Introduction 
Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. 
This type of cancer forms in the lining of nephrons, the very small tubes in the kidney that 
filter blood and transport waste to the urine. Kidney cancer is the 8th most common form 
of cancer in the U.S. with an estimate of 64,000 new cases and 14,000 deaths in 2014.1 
RCC is not a single disease, but a collection of different types of tumors, the most common 
are clear cell, papillary, and chromophobe which represent about 70-80%, 10-15%, and 3-
5% of all RCC cases respectively. Other rare types of RCC include collecting duct and 
medullary, however collectively they only represent less than 1% of all RCC cases. Each 
subtype of RCC is derived from various parts of the nephron and possess distinct genetic 
characteristics, histological features, and clinical phenotypes.2 Prognosis varies depending 
on stage and grade of each RCC subtype, but 5-year survival rates on average are about 
70% for clear cell, 80% for papillary, and 85% for chromophobe.3 Treatment for RCC 
includes surgery, radiation therapy, chemotherapy, immunotherapy, and targeted 
therapy.1,2 However, RCC is highly resistant to traditional chemotherapy and radiation 
therapy, and few patients benefit from immunotherapy as well.4,5 Over the past decade 
discoveries in different RCC tumor growth pathways have led to successful treatment of 
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different RCC tumors using targeted treatments.6 Thus, accurate RCC diagnosis and 
subtyping is important not only for prognostic value, but also for the prediction of targeted 
therapeutic response. 
As discussed in Chapters 1 through 4, DESI-MS imaging is an ambient ionization 
technique that measures the lipid profiles, specifically glycerophospholipid profiles, in 
tissues which is directly correlated to disease states when combined with histopathological 
evaluations.7,8 After disease state correlation, DESI-MS data is used by multivariate 
statistic methods (e.g. PCA or LDA) to create MS libraries which can be used for pattern 
recognition to classify samples based on disease (e.g. tumor or normal) and potentially 
complex relationships (e.g. tumor subtype, grade, or cell concentration). DESI-MS 
imaging has been previously applied to analyze lipid profiles in several canine and human 
cancers with successful differentiation of tumor and normal tissue in all cases.8-13 One of 
the previously analyzed human cancers was RCC14, however only two subtypes were 
investigated and sample numbers were limited for both. Further, the classification results 
for tumor versus normal were obtained separately for specimen of each subtype and then 
subtype classification results were obtained using all specimen. 
In this Chapter, analysis of RCC subtypes clear cell, papillary, and chromophobe, 
which represent about 99% of all diagnosed RCC cases, by DESI-MS imaging is discussed. 
The biochemical information obtained by DESI is explored for differentiation of tumor and 
normal tissue and further tumor subtypes. The goal of this work is to create a 
comprehensive MS library to be used for classification of surgical tissue obtained from 






5.2.1 Study Protocols 
 All tissue specimens were handled in accordance with approved institutional review 
board (IRB) protocols at Indiana University School of Medicine and Purdue University. 
Paired normal and tumor specimens for clear cell (n=20), papillary (n=20), and 
chromophobe (n=15) RCC subtypes were obtained from IUSM tissue procurement. Tissue 
were cryosectioned at 15 μm thicknesses and each matched pair was thaw mounted to a 
single glass microscope slide (10 replicate slides were made for each pair). One 
chromophobe specimen contained all adipose fat and could not be sectioned for MS 
analysis. Sections were stored at −80 °C prior to MS analysis. Tissue sections were allowed 
to come to room temperature and then dried under nitrogen for approximately 15 minutes 
in a desiccator prior to analysis. The same slide analyzed by DESI-MS imaging was H&E 
stained and examined by an expert pathologist to identify from tissue morphology the 
presence/absence of RCC and tumor subtype. 
 
5.2.2 DESI-MS Imaging 
 DESI was performed using a laboratory-built ion source, similar to the commercial 
2D source from Prosolia, Inc. (Indianapolis, IN, USA) and coupled to a linear ion trap mass 
spectrometer (LTQ) controlled by XCalibur 2.0 software (ThermoFisher Scientific, 
Waltham, MA). DESI-MS was carried out in the negative ionization mode with the 
automatic gain control (AGC) inactivated. The spray solvent used for DESI-MS was 
dimethylformamide (DMF)–acetonitrile (ACN), a morphologically compatible solvent, at 
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a 1:1 ratio (v/v), both solvents were purchased from Mallinckrodt Baker Inc. (Phillipsburg, 
NJ), and delivered at 1.0 μL min−1 flow rate using the instrument syringe pump. The DESI 
source parameters were: capillary temperature 275 °C, voltage applied to the stainless steel 
needle syringe 5 kV, capillary voltage −25 V, tube lens voltage −115 V, capillary incident 
angle 54°, spray to surface distance 3 mm, sample to inlet distance 5 mm, and nitrogen gas 
at 180 PSI. The tissue sections were analyzed using a moving stage with a lateral scan rate 
coordinated to the MS scan rate to produce a mass spectrum every 200 μm across each 
horizontal row. Horizontal rows were separated by a 200 μm vertical step, thus creating 
200 μm  x 200 μm pixels within each image. Full scan mass spectra were acquired in 
negative ion mode in the mass range m/z 200–1000. For statistical analysis of the evaluation 
dataset, a reduced mass range of 700–1000 was used, limiting the biochemical information 
to complex glycerophospholipids. 
 
5.2.3 Data Analysis 
 
5.2.3.1 DESI-MS Ion Images 
DESI ion images were prepared by the same method as described in Chapter 4. 
Briefly, data acquired using XCalibur 2.0 (.raw) were converted with an in-house program 
into files compatible with BioMap software (http://www.maldi-msi.org). BioMap was used 
to generate 2D ion images (retaining spatial relationships and displaying relative mass 
spectral abundance of particular mass-to-charge ratios) and select regions of interest (ROI) 
based on pathology. The data were then imported into Matlab. 
122 
 
5.2.3.2 Principal Component Analysis 
Multivariate analysis was performed using in-house MatLab routines. PCA was 
used to explore DESI-MS data and visualize the grouping of samples resulting from 
chemical similarity.15 Specimens excluded from statistics included two normal and one 
papillary. Two tumor tissue sections had subsections of normal tissue and where separated 
into two areas for statistics. One normal tissue section had a subsection of normal with a 
different spectral pattern, this tissue section was split into two separate ROIs for statistics. 
One tumor tissue section had a subsection of tumor with a different spectral patter, this 
tissue section was split into two separate ROIs for statistics.  MS data were normalized by 
standard normal variate (SMV) transform and column-centered (i.e. mean-centered). LDA 
was performed for discriminant classification after unsupervised data compression by PCA 
(i.e. PCA-LDA), as reported elsewhere.16 The first 8 principal components (PCs), 
accounting for ~90% of total data variation, were used. Model validation (i.e. evaluation 
of the predictive ability of the model) was performed by means of cross validation (CV). 
For this study, five cross-validation deletion groups were selected, meaning that all the 
samples were divided five times systematically in a training set (objects used for building 
the classification model) and a test set (remaining objects used to evaluate the predictive 







5.3 Results and Discussion 
 
5.3.1 DESI Imaging and Lipid Patterns 
 RCC is not a single disease, but a collection of different tumor types, most 
commonly clear cell, papillary, and chromophobe. Histopathological diagnosis of RCC is 
based on morphological and cytological features, such as morphological growth pattern 
and nuclear size and shape.2 Along with these features, RCC subtyping can be supported 
by immunohistochemistry to map the expression of proteins related to a specific subtype 
(e.g. expression of α-metylacil-CoA racemase (AMACR) for papillary RCC or c-kit 
expression for chromophobe RCC).17 Discussion in this Chapter aims to explore and 
establish a relationship between the lipid profiles obtained using DESI-MS and the tissues 
disease state (i.e. RCC or normal) and further RCC tumor subtypes. 
 Negative ion mode DESI-MS showed ionized fatty acids from m/z 200-350 (e.g. 
oleic acid, m/z 281), fatty acid dimers from m/z 400-700 (e.g. oleic acid + oleic acid, m/z 
563), and glycerophospholipids (GPL) from m/z 700-1000 (e.g. PI(38:4), m/z 885). The 
lipid constituents used to investigate disease state were primarily GPLs (m/z 700-1000) as 
they were empirically found to contain less analytical variability, providing more 
consistent and clear distinction with regards to disease state. The major GPL ions observed 
included were phosphatidylinositols (PI), phosphatidylserines (PS), 
phosphatidylethanolamines (PE), and phosphatidylglycerols (PG). These lipids can be 
observed in the average normal, clear cell, papillary, and chromophobe mass spectrum in 
Figure 5-1 A, B, C, and D respectively. Visually, the differences between lipid profiles of 
normal and tumor can be very clear (i.e. normal vs. clear cell and papillary) or very subtle 
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(i.e. normal vs. chromphobe). One of the clear differences observed is between the lipid 
ratio of ions m/z 794 and 885 where in the normal lipid profile m/z 794 has almost an 
identical peak height to m/z 885, however in clear cell and papillary m/z 794 has about a 
third of the peak height of m/z 885. This difference is not as readily observed between 
normal and chromphobe, although chromophobe seems to have less abundance of m/z 794 
than normal, a better visualization difference between normal and chromophobe are the 
ratios of m/z 723, 747, and 773 where m/z 723 and 747 are almost identical in peak height 
and double that of m/z 773 in normal, but in chromophobe m/z 773 is almost double m/z 
747 in peak height as is the same with m/z 747 to m/z 723.  Some of these distinctions are 
clear between the average spectra of specific disease states, however visual interpretation 
of ~100 unique data points would be difficult to address. Therefore, multivariate statistical 
analysis is needed to efficiently explore the chemical information contained in the mass 
spectra.  
 
5.3.2 Classification of RCC, Tumor Subtypes, and Normal Tissue using Lipid Profiles 
 Qualitative and quantitative statistical analysis of the lipid profiles obtained from 
tissue was explored for molecular-based differentiation of disease state (i.e. normal and 
RCC) and tumor subtype (i.e. clear cell, papillary, and chromophobe). Qualitative analysis 
was performed by principal component analysis, an unsupervised statistical tool, to 
produce 2-dimensional score plots displaying the lowest-order principal components (PCs) 
for which separation between disease state and subtype was visually apparent. 
Corresponding loading plots were also produced to display the ions which contribute the 
most to each PC. Shown in Figure 5-2 A and B is the score and loading plot, respectively, 
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related to RCC (red objects) and normal (dark green objects) separation and shown in 
Figure 5-3 A and B is the score and loading plot related to tumor subtype (red objects – 
clear cell, yellow objects – papillary, and orange objects – chromophobe) and normal (dark 
green objects) separation. Although some separation is observed in the 2-dimensional plots, 
PCA is multidimensional method and separation can occur in many of them. 
 A discriminant classification model created by PCA-LDA was used to determine 
the quantitative performance of the PCA results (i.e. tumor vs. normal separation and tumor 
subtype vs. normal separation) from the DESI-MS data. The first eight PCs were which 
correlated to ~90% of the total variance of the dataset (~10% of total variance consists of 
noise). Cross-validation was performed using five deletion groups resulting in an average 
prediction classification rate of 92%, Table 5.1a, for disease state (i.e. normal versus 
tumor). Classification of tumor subtype was also performed using the same method 
described above with an average predicted classification rate of 85%, Table 5.2a. The 
predicted classification of papillary RCC (73.3%) was relatively poor in comparison to the 
other states (normal - 90.7%, clear cell – 80.1%, and chromophobe – 80%), likely the result 
of convolution within the PCs, specifically, convolution with clear cell RCC. Clear cell 
RCC is known to have much higher lipid content including cholesteryl esters18 (CEs) which 
are readily observed in the positive ion mode when silver is added to the DESI solvent 
spray.19,20 It is hypothesized that detection of CEs and similar lipids in the positive mode 
using silver adduct experiments may help the separation of papillary and clear cell 





 DESI-MS imaging was used to obtain lipid profiles from normal kidney and clear 
cell, papillary, and chromophobe RCC subtypes. PCA-LDA was used to build discriminant 
classification models to quantitatively asses PCA separation of disease states (i.e. tumor 
vs. normal) and tumor subtypes (i.e. clear cell, papillary, and chromophobe vs. normal). 
The average prediction rate for disease state classification was 92%. Further classification 
of RCC subtype produced an average prediction rate of 85%. The 92% prediction rate for 
tumor and normal discussed in this Chapter was similar to the average of the individual 
classification rates (i.e. classification of tumor and normal was performed separately for 
clear cell and papillary) reported in previous work, 92.2% for clear cell vs. normal and 
85.7% for papillary vs. normal or an average prediction rate of 89%. The previous work 
also reported classification of clear cell and papillary subtypes with an average prediction 
rate of 76.3%, this rate is much lower than the average prediction rate of 85% for clear cell, 
papillary, and chromophobe discussed in this Chapter. It is thought that the dramatic 
increase in RCC subtype prediction rate is related to the increase in sample size from the 
previous work to this work. Overall, the goal of building a classification model for disease 
state and subtype differentiation for RCC was successful. Future work includes continuing 
to increase sample size, and validating the classification model against surgical tissue of 
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Table 5.1 Classification Rate and Confusion Matrix Information for Tumor and Normal 
Disease States 
 




(b) Confusion Matrix 
Species Normal Tumor 
Normal 49 6 





Table 5.2 Classification Rate and Confusion Matrix Information for Tumor Subtype and 
Normal Disease States 
 
(a) Tissue Classification Rates 
Normal 90.7% 




(b) Confusion Matrix 
Species Normal Clear cell Papillary Chromophobe 
Normal 49 3 2 0 
Clear cell 2 13 1 0 
Papillary 0 3 11 1 







Figure 5-1 Average negative ion mode mass spectrum for A) normal kidney tissue, B) clear 






Figure 5-2 A) PCA score plot of normal (dark green objects) and RCC (red objects) 







Figure 5-3 A) PCA score plot of normal (dark green objects), clear cell RCC (red objects), 
papillary RCC (yellow objects), and chromophobe RCC (orange objects) samples and B) 
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Touch spray mass spectrometry for in situ analysis
of complex samples†
Kevin S. Kerian, Alan K. Jarmusch and R. Graham Cooks*
Touch spray, a spray-based ambient in situ ionization method, uses a small probe, e.g. a teasing needle to
pick up sample and the application of voltage and solvent to cause field-induced droplet emission.
Compounds extracted from the microsample are incorporated into the sprayed micro droplets.
Performance tests include disease state of tissue, microorganism identification, and therapeutic drug
quantitation. Chemical derivatization is performed simultaneously with ionization.
Introduction
Ambient ionization produces ions outside the mass spectrom-
eter from samples in their native state.1,2 Desorption electro-
spray ionization (DESI)3 was reported in 2004, and since then
more than forty ambient ionization methods have been
described.4–6 In some experiments such as DESI a single agent
(charged droplet impact) is used to desorb the analyte and to
effect its ionization. In others, two separate agents are used to
perform the key operations of desorption and ionization: for
example, desorption can be achieved using a laser, plasma or
droplet and ionization can take the form of electrospray ioni-
zation, atmospheric pressure chemical ionization or laser
ionization. One of the main characteristics of ambient ioniza-
tion is the speed of analysis – it requires a few seconds for the
entire process of sampling, ionization and recording of mass
spectra. This feature is the result of eliminating or greatly
relaxing sample pre-treatment, including avoiding separation
techniques prior to mass spectrometry. Ambient ionization
mass spectrometry displays wide applicability combined with
high sensitivity and the highmolecular specicity characteristic
of mass spectrometry.7,8 Ambient methods based upon spray
ionization include DESI,3 nanospray desorption electrospray
ionization (nanoDESI),9 liquid microjunction surface-sampling
probe (LMJ-SSP),10 probe electrospray ionization (PESI),11 and
others. In each case solvent and high voltage are used to
generate the strong electric eld needed to produce charged
secondary droplets which leave the substrate carrying dissolved
analyte into the mass spectrometer. The emitted charged
droplets undergo coulombic ssion when sufficient surface
charge is accumulated as a result of solvent evaporation,
eventually yielding analyte ions by mechanisms that parallel
those in electrospray ionization.
A family of methods exist which rely on spray based ioni-
zation from substrates:12 these methods include paper spray
(PS),13 PESI,14 and leaf spray (LS).15 Substrate spray methods
generate ions from sharp tips, naturally present or created,
and require a minute amount of sample. PESI, an early
example of ambient probe based ionization source, allowed
the analysis of liquid samples in situ. PESI utilizes smooth
metallic objects with sharp tips (e.g. acupuncture needles) to
transfer aliquots of sample solution for MS analysis and has
been applied by Hiroaka et al. to tissue analysis in cancer
diagnostics,16,17 protein analysis, and agrochemical analysis.18
Metallic probes such as those used in PESI provide a non-
porous surface primarily serving as a means of analyte trans-
port and application of high voltage. Organic materials (paper,
wood, and plant parts) have been used in substrate-based
electrospray sources. Substrates based on organic materials are
not only capable of generating ions but also provide a varying
ability for selective absorption of components of a mixture.
Mass spectra were recorded from wooden toothpicks by Yao
and colleagues19 who detected pharmaceuticals in applied
homogenous solution, and similarly by Chen et al. using
bamboo nibs, similar to those used in calligraphy.20 Analysis of
powders, sampled from locations otherwise difficult to access
was achieved using moistened wooden toothpicks.21 PS is
similarly capable of in situ sampling with the detection of
analytes by wiping as in the detection of agrochemicals on the
surface of an orange.22
Touch spray (TS) ionization falls into this family of substrate
spray methods, using a probe (e.g. needle) to sample material
and solvent and an electrical potential to desorb analyte and
transfer it in ionic form into a mass spectrometer. TS allows in
situ sampling of materials from which ions are generated once
solvent (as needed) and a potential are applied. It is closely
related to the metallic probe substrate techniques such as PESI
and organic substrate techniques such as PS, and characterised
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by the ability to sample and absorb materials such as solid
powers, trace amounts of solids on surfaces, solutions, and
heterogeneous matrices (e.g. tissue) onto a probe. Absorbed
material can be transported from the point of origin to the MS
in two stages, rst by physical transfer of a small sample and
then by transfer of dissolved analytes in the sprayed droplets.
TS, as with other spray-based ambient ionization methods,
allows nearly simultaneous chemical derivatization and ioni-
zation, generating derivatives that can increase signal and
enhance qualitative identication. This publication describes
the methodology of TS and explores applications, with
emphasis on in situ analysis via illustrative examples.
Results and discussion
Touch spray ionization
Touch spray ionization is aimed specically at in situ analysis of
complex samples. Analytes are transferred from a particular
location in the sample using a roughed probe. Subsequently,
spray ionization (see ESI Fig. 1†) transfers the ionized analyte to
the mass spectrometer for analysis. The TS method incorpo-
rates a manual method of collecting a MS sample: sampling is
remote to the mass spectrometer and aer manual transfer
onto a probe, MS is performed directly from the sampling
device. It is not necessary to use a specic probe material or that
it have a particular physical form: the transfer of a minute
amount of material for MS analysis can be achieved by
touching, scratching, dipping, swiping, or otherwise attaching
sample material. The probe is then aligned with the mass
spectrometer, high voltage is applied, solvent is added, and
mass spectra are recorded. In these experiments the touch spray
probe was aligned with the atmospheric inlet (0.5–20 mm away)
and an appropriate voltage (3.0–5.0 kV) was applied to generate
a stable electrospray signal without a corona discharge. Solvent
was either applied manually via pipette (0.1–2 mL, which
provided mass spectral signals lasting only a few seconds) or
continuously via a syringe pump (yielding continuous signal
until analyte exhaustion, typically >1 min).
One suitable probe is a teasing needle (Fig. 1); these are
metallic, possess a sharp tip, and are roughened. The metallic
and roughened features appear to be benecial when sampling
and transferring material, such as biological tissue. The
crevasses in the roughened surface holdmaterial during sample
transfer and analysis, facilitating analyte extraction. In addi-
tion, in the case of teasing needles, the angled feature was
found to increase reliability, as it accommodated solvent
application and was observed to promote solvent ow.
Complete wetting of the probe's surface improved extraction of
analytes and emission of solvent microdroplets, a feature which
was not observed in all probes evaluated.
Touch spray is user-guided, placing limits on the rate and
reproducibility of sampling. It is therefore semi-quantitative
with performance dependent on user experience. However, it
allows ready assessment of the presence or absence of analytes
in situ, information that is critical for applications in elds such
as forensics and quality control while also providing the ability
to monitor relative changes in ion abundances in applications
such as cancer diagnostics.
Detection of lipids from biological tissue
The lipid composition of mouse brain tissue has been exten-
sively studied using ambient ionization mass spectrometry (e.g.
DESI)23 and therefore constitutes a biological standard by which
to qualitatively measure the performance of touch spray ioni-
zation. A minute amount of cellular and extracellular material
can be transferred to a touch spray probe using light abrasive
force on the biological material. For the sake of demonstration,
mouse brain tissue sections were sampled in this manner
removing material in a circle (diameter <1 mm). Touch spray
mass spectra displayed in Fig. 2 are similar to those acquired
with DESI, ESI Fig. 2,† in the negative ion mode is dominated by
signals due to fatty acids (m/z < 300), fatty acid dimers (m/z 300–
700), and glycerophospholipids (m/z 700–1000). The relative
abundances of m/z 888.5 (main constituent from previous
studies, sulfatide 24 : 1), 788.5 (phosphatidylserine 36 : 1),
834.5 (phosphatidylserine 40 : 6), and 885.5 (phosphatidylino-
sitol 38 : 4) were used to qualitatively assess neural composition
(white and grey matter) as shown in Fig. 2. The transverse plane
of mouse brain possesses le-right hemisphere symmetry,
visible in the various staining features (e.g. cerebellum and
corpus callosum). Touch spray was performed at six positions
(Fig. 2) annotated upon the H&E stain. The touch spray mass
spectra from the mouse olfactory bulb (Fig. 2, point 1) displayed
unique ions detected atm/z 806.5 (PS 38 : 6) and 909.5 (PI 40 : 6)
corresponding to parallel ndings using DESI.23 Similarly, the
mass spectra recorded from point 2 indicated a high percentage
of white matter, corresponding to the corpus callosum. The
spectra recorded at point 5 show a high percentage of gray
matter (periaqueductal gray and/or cerebellum). At other points
Fig. 1 Sampling of (A) solids and (B) liquids by touch spray ionization
using an angled teasing needle. (C) Application of high voltage and
solvent at themass spectrometer causes release of analyte-containing
charged droplets.














































a mixture of gray and white matter was observed with point 3
corresponding to the thalamus, point 4 to periaqueductal gray
with white matter potentially from the posterior commissure,
and point 6 primarily white matter from the granular layer of
the cerebellum with some gray matter.
The reproducibility of touch spray was assessed using
coronal mouse brain sections. These sections are comprised of
either grey or white matter each possessing different glycer-
ophospholipids, reected in the spectra, and whose distribu-
tion is symmetrical between right and le hemispheres. Touch
spray was performed at six equally spaced points across one
coronal section (ESI Fig. 3†). Mass spectra were reproducible in
terms of the prominent glycerophospholipids ions seen and
also in terms of their approximate relative intensities. They were
similar between points of related neural composition; for
example, A and F indicated greymatter which produces patterns
including a base peak atm/z 834.5 and major peaks atm/z 788.5
and 885.5 whereas B and E displayed an ion m/z 888.5 with a
higher ratio of m/z 888.5 to 834.5 than m/z 788.5 or 885.5 to
834.5 indicating the presence of white matter.
Ex vivo detection of malignant prostate cancer
The ability to discriminate prostate malignancy from non-
malignant states is vital for improving the care of patients, and
could be furthered by advances in molecular-based diagnostics.
DESI-MS can be used to distinguish cancer from normal tissue
in human brain tumors and to classify tumor subtypes, grades,
and tumor cell concentrations.24 TS is being applied to prostate
cancer to assess malignant and non-malignant states. Prostate
cancer tissue from radical prostatectomy specimens was eval-
uated with TS using DESI imaging to validate the TS data.
Samples were collected using a disposable biopsy gun and
sectioned to allow evaluation by histopathology in serial
sections (<50 mm).
DESI and TS spectra acquired from a region of malignant
prostate cancer, determined by histopathology, are presented in
Fig. 3A and B, respectively. The H&E stained biopsy section
shown in Fig. 3C is a sample analyzed by DESI-MS with the
cancerous region outlined. TS-MS was performed on the
Fig. 2 (Upper left) H&E stain of a transverse mouse brain section after repeated sampling, annotated, by TS-MS (lower left) sampling point 1,
corresponding to the olfactory bulb which contained unique lipids detected at m/z 806.3 and 909.4 (right) TS-MS from annotated sampling
points displaying various levels of white and gray matter.
Fig. 3 (A) DESI-MS and (B) TS-MS of region outlined in (C) corre-
sponding to prostate malignancy as determined by histopathological
evaluation.














































adjacent section. The phospholipid region (m/z 720–900) was
observed to possess many similarities between the two methods
such as the ratio and abundance of ions at m/z 786.5 (PS 36 : 2),
788.5 (PS 36 : 1), 861.5 (PI 36 : 4), 863.5 (PI 36 : 3), and 885.5 (PI
38 : 4). The major differences seen between the spectra were the
chlorinated phosphotidylcholine adducts present in the TS
spectrum at m/z 792.5 (PC 34 : 2)/794.5 (PC 34 : 1), 818.5 (PC
36 : 3)/820.5 (PC 36 : 2), and 844.5 (PC 38 : 4)/846.5 (PC 38 : 3).
The chlorinated adducts in the TS spectrum indicate a lower
salt tolerance in TS than in DESI.25
In vitro detection of bacteria
Interest in in vitro detection and identication of bacteria by
mass spectrometry has increased signicantly.26 The ability to
directly detect biomolecules such as proteins and lipids by
matrix assisted laser desorption ionization (MALDI)27 and
electrospray ionization (ESI), respectively, has reduced diag-
nosis time while improving accuracy due to high molecular
specicity. Touch spray was investigated for its applicability to
in vitro detection. A minute amount of material, as little as 1%
of a single bacterial colony, was required for mass spectral
analysis. The data presented in Fig. 4 were acquired in the
negative ionization mode with automatic gain control (AGC) in
a burst of signal lasting just a few seconds. Repeated sampling
of the E. coli culture yielded ionized lipids of identicalm/z values
and relative spectral intensity, while absolute intensity varied
with sampling. The spectra contained phospholipids in a prole
from approximatelym/z 660–780, including odd-carbon number
fatty acid phospholipids (e.g. m/z 719.5, phosphatidylglycerol
32 : 1). It was determined empirically that the addition of
CHAPS, a surfactant, to the methanol spray solvent increased
signal and stabilized the TS spectra. Addition of CHAPS at
0.01% was determined to have the most benecial effect
without undue interference from the CHAPS chloride adduct
(m/z 649.8). The observed surfactant effect on improving spectra
in ambient ionization due to reduction in surface tension is well
known.28
Forensics: bulk and trace detection of illicit drugs
Forensics, in particular illicit drug analysis, oen requires the
ability to detect compounds in situ from matrices including
powders, drug residues on surfaces including clothing, and
illicit drugs in solution. Mass spectrometry is certainly capable
of analyzing all of these types of samples when using various
types of sample preparation. Touch spray offers a method by
which to analyze these sample types without preparative steps.
Drug residues on clothing typically require extraction in
solvents whereas with TS the material can be lightly rubbed
absorbing minute amount of drugs while removing negligible
amounts of the cloth. This ability was demonstrated by the
detection of cocaine from a dried blood spot containing 10 ng of
the spiked drug on blue cloth, ESI Fig. 4†. A homogenous
solution containing 400 ppb each of MDMA, cocaine, and
methamphetamine was sampled by dipping the TS probe into
the solution and dried at ambient temperature (<1 minute). The
mass spectrum (Fig. 5) was recorded by the addition of spray
solvent and a high voltage; it displays the ions at m/z 150.3,
194.3, and 304.3 for each of the drugs in the solution,
respectively.
Therapeutic drugs
Therapeutic drug monitoring aids in maintaining drug
concentrations within the benecial range, maximizing thera-
peutic effects while minimizing the risk of harmful overdosing
or wasteful undosing. Ambient ionization methods such as PS
have used whole dried blood or whole blood mixed with a
coagulant to quantitatively measure the concentrations of
pharmaceuticals.29 Whole bovine blood spiked with imatinib, a
therapeutic used for the treatment of chronic myelogenous
leukemia, and with its deuterated isotopomer added as internal
standard, were analyzed over a range of concentrations. Using
the teasing probe, blood was sampled by dipping once directly
into the blood to a xed depth, waiting <1 min to dry aer
dipping, and analyzing directly aerwards. The quantitative
performance was similar to that of PS with a linear response
Fig. 4 Negative ion mode TS-MS displaying E. coli phospholipids in a
sample consisting of 1% of a single colony, showing phospholipids and
the chloride adduct of CHAPS, a surfactant added to the spray solution.
Fig. 5 Positive ion mode TS-MS of illicit drugs, methamphetamine,
MDMA, and cocaine, at 400 ppb in homogenous solution sampled via
a single dip of a touch spray probe.














































across the concentration range tested (Fig. 6).30 It could be
increased further using MS/MS. Furthermore, the percentage
error (n ¼ 5) was <10% for imatinib concentrations greater than
1 ppm, a value within FDA guidelines (see ESI Table 1†). It is
envisioned that a modied TS probe may be useful as a semi-
quantitative tool that could be used as a nger-prick device
which could be directly used to measure the concentration of
therapeutics in whole blood.
Residual agrochemical detection in foods
Agrochemicals are applied to foods in an attempt to prolong
crop quality while attempting to limit potentially adverse
health effects. Oranges and other citrus fruits are commonly
treated (systemically or sprayed post-harvest) with fungicides
such as thiabendazole, leaving a trace amount of material on
the surface of the orange peel. Agrochemical levels are moni-
tored and regulated in the United States, typically by chro-
matographic separation prior to MS analysis. This procedure is
not readily accomplished in situ, limiting thorough screening
of foodstuffs; however, fungicides have previously been repor-
ted to be monitored using paper spray ionization in situ.31 A
non-organic orange purchased from a national grocer was
subjected to analysis by TS, in which the probe was used to
sample 4 cm2 area of the peel. The spectrum, ESI Fig. 5,†
includes ions due to protonated thiabendazole (m/z 202) and
imazalil (m/z 297). The acquired spectrum matches previously
reported fungicides detected from non-organic oranges using
an alternative ambient ionization method (i.e. low temperature
plasma).22
Elaborations
Reactive touch spray ionization. TS-MS experiments
exploiting simultaneous chemical derivatization and ionization
(i.e. reactive ambient ionization) were explored. Derivatized
versions of analytes oen give greater signals in MS analysis of
complex mixtures. The use of appropriate reagents allows
reduction of complex spectra via analyte signal enhancement or
characteristic m/z value shis. Reactive touch spray was
explored with known types of ambient reactions including non-
covalent adduct formation, (e.g. silver adduction of olens32)
and covalent bond formation (e.g. betaine aldehyde with alco-
hols33). Cholesteryl linoleate and adrenosterone were sampled
from homogenous solution in a dipping fashion by TS. The
unsaturated aliphatic functionality of cholesteroyl lineolate
reacted with silver nitrate (4 ppm, acetonitrile) forming non-
covalent adducts detected at m/z 755.4 and 757.4 (ESI Fig. 6†)
corresponding to [107Ag + cholesteroyl lineolate] and [109Ag +
cholesteroyl lineolate]. Covalent bond forming reactions tar-
geting the ketone functional group in adrenosterone, a choles-
terol-related hormone, were accomplished using Girard's
Reagent P and hydroxylamine (ESI Fig. 7†). The detection of
cholesterol from bovine blood was accomplished using betaine
aldehyde which reacts with a poorly ionizable hydroxyl func-
tionality creating a positively-charged quaternary amine deriv-
ative (ESI Fig. 8†).
Continuous touch spray ionization. Most applications of
touch spray only require brief recording of the MS signal to
obtain the desired information, as outlined above. However, if
the application dictates a longer signal duration, touch spray
can be coupled to a solvent delivery system (solvent pump) to
provide solvent at controlled ow rate to produce stable ion
currents. The solvent is added continuously at the same loca-
tion where discrete additions of solvent produce spectra,
yielding a signal that lasts until analyte exhaustion. An illus-
trative gure is presented in ESI Fig. 9† including parameters
determined used with the bent teasing probe.
Conclusions
Touch spray (TS) ionization is a spray-based ambient ioniza-
tion method capable of in situ sampling of complex mixtures.
Rapid, reproducible, and specic chemical information is
obtainable from biological tissue including mouse brain and
human prostate cancer. Differentiation of specic anatomical
regions and disease states based on lipids detected in the
negative ionization mode appears to be possible. Application
in the detection of bacteria is promising, the detected lipids
allowing for differentiation of bacteria. TS-MS of solutions,
including blood, could allow for numerous applications in
forensics (e.g. illicit drugs) and medicine (e.g. therapeutic drug
monitoring). The user-guided nature of TS allows for the
unique sampling abilities while hindering absolute quantita-
tion. Further, as is the case for many ambient ionization
techniques, simultaneous ionization and chemical derivatiza-
tion enhances the signal for specic analytes or groups of
analytes.
Further development of TS-MS including the sampling
methodology, probe design, and probe material could lead
to improved quantitative performance and reproducibility.
The ultimate application of the TS technology would be
in combination with miniaturized mass spectrometer
systems to allow for in situ sampling, ionization, and mass
analysis.
Fig. 6 Full scan calibration curve of imatinib. Data points represent the
average value for repeat analysis (N ¼ 5) and error bars corresponding
to the standard deviation. Linear regression performed by unweighted
least squares analysis from 1 ppm to 13.3 ppm.
















































The TS probe used is a commercially available teasing needle
purchased from Fisher Scientic (Pittsburgh, PA, USA) while
multiple variants also were tested.
Materials
The spray solvent used for MS acquisition was methanol,
purchased from Mallinckrodt Baker Inc. (Phillipsburg, NJ), and
applied manually via an adjustable pipette (Eppendorf
Research-2.5 mL). Additional spray additives including 3-
[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS) was purchased from Sigma-Aldrich (St. Louis, MO).
Therapeutic drugs were acquired from Cerilliant (Round Rock,
Texas, USA). Drugs were stored at20 C until diluted in bovine
blood to appropriate concentrations. Illicit drugs were acquired
from Cerilliant (Round Rock, Texas, USA). Drugs were stored at
20 C until diluted to appropriate concentrations. Non-
organic orange was purchased from national grocer for agro-
chemical MS experiments.
Mouse brain tissue
Mouse brain tissue was acquired from JAX® Mice and Services
(Bar Harbor, Maine, USA). A mouse brains was sectioned at 15
mm and thaw mounted onto glass microscope slides. The slides
were stored in closed containers at20 C; prior to analysis they
were allowed to come to room temperature and dried in an
electronic desiccator for approximately 20 minutes.
Prostate tissue
Radical prostatectomy specimens were obtained from con-
sented patients via Indiana School of Medicine (Indianapolis,
IN). Biopsies were obtained using a disposable biopsy gun in
accordance with an IRB approved protocol. Biopsies were
frozen, cryosectioned at 15 mm and thaw mounted to glass
microscope slides. Sections were stored at 80 C prior to
analysis. Histopathology was performed upon H&E staining
prostate biopsies by an expert pathology.
Bacteria culturing
E. coli strains were supplied by bioMe´rieux, Inc. (Hazelwood,
MO) and cultured from frozen samples stored at 80 C in
TSAB. Bacteria were cultured on TSA with 5% sheep blood
(Remel, Lenexa, KS) and incubated in a VWR incubator (Chi-
cago, IL) at 37 1 C for approximately 24 h, sub-cultured for an
additional 24 h, and then used in TS-MS experiments.
Instrumentation
A LTQ linear ion trap (Thermo Fisher Scientic) was used in
experiments unless otherwise specied and carried out with the
auto gain control (AGC) activated.
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Differentiation of prostate cancer from normal
tissue in radical prostatectomy specimens by
desorption electrospray ionization and touch
spray ionization mass spectrometry†
K. S. Kerian,a A. K. Jarmusch,a V. Pirro,a M. O. Koch,b T. A. Masterson,b L. Chengc and
R. G. Cooks*a
Radical prostatectomy is a common treatment option for prostate cancer before it has spread beyond the
prostate. Examination for surgical margins is performed post-operatively with positive margins reported
to occur in 6.5–32% of cases. Rapid identification of cancerous tissue during surgery could improve surgi-
cal resection. Desorption electrospray ionization (DESI) is an ambient ionization method which produces
mass spectra dominated by lipid signals directly from prostate tissue. With the use of multivariate statistics,
these mass spectra can be used to differentiate cancerous and normal tissue. The method was applied to
100 samples from 12 human patients to create a training set of MS data. The quality of the discrimination
achieved was evaluated using principal component analysis – linear discriminant analysis (PCA-LDA) and
confirmed by histopathology. Cross validation (PCA-LDA) showed >95% accuracy. An even faster and
more convenient method, touch spray (TS) mass spectrometry, not previously tested to differentiate dis-
eased tissue, was also evaluated by building a similar MS data base characteristic of tumor and normal
tissue. An independent set of 70 non-targeted biopsies from six patients was then used to record lipid
profile data resulting in 110 data points for an evaluation dataset for TS-MS. This method gave prediction
success rates measured against histopathology of 93%. These results suggest that DESI and TS could be
useful in differentiating tumor and normal prostate tissue at surgical margins and that these methods
should be evaluated intra-operatively.
Introduction
Prostate cancer is estimated to be the most commonly diag-
nosed cancer in the United States, representing 14% (233,000
cases) of all newly diagnosed cancer cases in 2014.1 Treat-
ments for prostate cancer include surgery, radiation therapy,
and hormone therapy, the choice between them being primar-
ily dependent on the patient’s health and the stage of the
cancer. At the time of diagnosis, over 90% of prostate cancer
cases have tumors confined to the prostate gland, representing
stage 1 or stage 2. Before cancer has spread to the outer
layer of the prostate, the disease is curable through complete
surgical resection by radical prostatectomy (RP).2 Standard
practice relies on preoperative measurements such as rectal
examination and clinical biopsy data to guide surgical resec-
tion. Positive surgical margins are only identified after com-
pletion of the surgery and their incidence is reported to range
from 6.5–32%.3
Needle biopsies are used for early diagnosis of prostate
cancer, however cancer detection using such biopsies is prone
to false negatives, reportedly up to 25%.4 Difficulty in diagno-
sis is the result of the limited sample size, the limited number
of malignant glands among many benign, and confusion of
benign histological features which mimic prostate cancer such
as paraganglia or xanthoma. Immunohistochemistry (IHC) has
been used to label p63, a marker for basal cells, which is
present in benign and absent in cancerous tissue. However,
negative staining is not reliably diagnostic given the limited
number and sizes of samples. Positive staining for α-methyl-
acyl-CoA racemase (AMACR) can be used since it is greatly up-
regulated in cancer, but this method too has pitfalls with
false negative rates up to 20–30% in cases such as pseudo-
hyperplastic, atrophic, and foamy gland adenocarcinoma of
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c4an02039a
aPurdue University, Department of Chemistry and Center for Analytical
Instrumentation Development, Purdue University, West Lafayette, IN 47907, USA.
E-mail: cooks@purdue.edu
bIndiana University School of Medicine, Department of Urology, Indiana University
School of Medicine, Indianapolis, IN 46202, USA
cIndiana University School of Medicine, Department of Pathology and Laboratory
Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
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the prostate.5 Currently unrepresented in prostate molecular
diagnostics is the use of the lipid constituents of tissue,
either in early diagnosis or in post-surgical tumor margin
diagnostics.
Lipid constituents of tissues are readily measured by
ambient ionization MS methods such as desorption electro-
spray ionization MS (DESI-MS). The basis for ambient ioniza-
tion is sample examination in the ambient environment with
little to no prior sample preparation.6 The two methods used
in this study, DESI and touch spray (TS) ionization7 fall into
this category as do others like nanospray desorption electro-
spray ionization (nanoDESI),8 probe electrospray ionization
(PESI)9 and laser ablation electrospray ionization (LAESI).10
A number of recent studies have reported the application of
mass spectrometry (MS) as a molecular diagnostic tool for
cancer. Zare and coworkers used DESI imaging with statistical
analysis methods to classify gastrointestinal cancer tissues
from banked and surgical specimens.11 Agar and coworkers
showed that it is possible to distinguish diseased from healthy
brain tissue using a library of mass spectra characteristic of
particular disease states.12 The work on brain cancer has
allowed clear differentiation of healthy from diseased tissue as
well as glioma subtype, the stage of the disease in particular
tumor regions, and the tumor cell concentrations at particular
locations.13 Another mass spectrometry method, ultraperfor-
mance liquid chromatography MS, has been shown to accu-
rately identify prostate cancer from serum using a metabolite-
based assay.14 It is possible to recognize in these and related
studies the beginnings of a significant effort to perform cancer
molecular diagnostics through the use of mass spectrometry
(MS).
The origins of recent interest in diagnostics by mass spec-
trometry can be traced to the development of matrix-assisted
laser desorption ionization (MALDI) imaging and its appli-
cation to mapping the distribution of proteins and peptides in
tissue sections.15,16 Ambient ionization methods which do not
use matrices have also given highly encouraging results,
especially for small molecules including drug metabolites,
hormones and lipids.17 The earliest application of DESI to
cancer diagnosis demonstrated changes in lipid profiles in
normal human liver tissue compared to metastatic liver adeno-
carcinoma. This study established the fact that tumor margins
can be recognized by mass spectrometry imaging.18 Sub-
sequent work using DESI differentiated tumor from normal
tissue using lipid profiles in kidney cancer,19 bladder cancer,20
testicular cancer,21 and brain cancer.12,13,22,23 The develop-
ment of ambient ionization methods for cancer diagnostics
was accelerated by the rapid evaporative ionization mass spec-
trometry experiments of Takáts and coworkers.24 In this
approach, the smoke produced during electrosurgical dissec-
tion is transferred and analyzed by a mass spectrometer. The
smoke contains phospholipids and other biomolecules
released from the region being resected and comparison to a
library of spectra allows tissue identification. DESI and TS
are both spray-based ambient ionization methods. However,
their respective features make them suitable for different
tasks. DESI-MS is primarily an imaging technique, allowing
collection of mass spectra, pixel by pixel, to create 2D mole-
cular images. The collected data can be assembled in hyper-
spectral datacubes25 from which 2D ion images corresponding
to specific components can be extracted to show the spatial
distribution and relative amounts of analytes. Applications of
DESI in distinguishing diseased and non-diseased tissue rely
on the use of multivariate statistics,25 typically principal com-
ponent analysis (PCA) and partial least squares discriminant
analysis (PLS-DA). DESI provides a key connection between the
information from histopathology and the characteristic mass
spectrum that is produced for each tissue and disease type
because the same (or adjacent) tissue sections analyzed by
DESI can be evaluated by the pathologist. On the other hand,
TS-MS is a user-guided method in which a spot of interest is
directly sampled with a probe, e.g. teasing needle, and trans-
ferred to the interface of a mass spectrometer, and ionized
by the application of solvent and high voltage. TS produces
information rich spectra which are similar to DESI, but in a
localized and very rapid process which typically takes a few
seconds.
We explore the potential of DESI-MS and TS-MS for prostate
cancer differentiation through in vitro analysis of radical pros-
tatectomy specimens. First, DESI-MS was used to establish the
relationship of MS features to pathology and then touch spray
was used to characterize unknown tissue samples. Training
sets for both methods were built using data obtained from 12
radical prostatectomy specimens and evaluated by PCA and
linear discriminant analysis (LDA). Both methods resulted in
>95% correct sample identification when confirmed against
histopathology. A TS-MS test dataset, obtained from another
six radical prostatectomy specimens, was used for further
evaluation of the method using a non-targeted analysis of the
prostate tissue samples.
Results and discussion
DESI and TS lipid profiles and training datasets
Prostate cancer is a heterogeneous disease. It is commonly
diagnosed by histopathology which at times can be ambigu-
ous. The morphological variations that are the basis for diag-
nosis by histology result from underlying biochemical
changes. The two main criteria for diagnosis are atypical
architectural features (e.g. perineural infiltration) and atypical
cytological features (e.g. enlarged nuclei). Prostate cancer diag-
nosis does not currently use the lipid components of the can-
cerous cells or tissue. Thus, complementary information
provided by direct molecular diagnosis of prostate cancer by
mass spectrometry could be useful to improve decision-
making strategies. In this study, two different ionization tech-
niques, DESI and TS, were used to acquire lipid profiles and
investigate differences between tumor and normal tissue. The
biochemical features recovered by DESI and TS were also com-
pared, since each ambient ionization technique provides
unique capabilities.
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For prostate tissue, the primary components of lipid pro-
files (detected as negative ions) are glycerophospholipids:
phosphotidylethanolamines (PhE), phosphotidylserines (PhS),
phosphotidylcholines (PhC), and phosphatidylinositols (PhI).
These lipids can be observed in the average normal
(74 samples) and tumor (26 samples) mass spectra shown in
Fig. 1 for DESI (A and B) and TS (C and D). Many of the same
differences between normal tissue and tumor are seen in both
DESI and TS average spectra. These include ratio changes for
ions m/z 788 and 885, an increase in relative abundance of
ions m/z 786, 835, 861, 863, and a decrease in relative abun-
dance of ions such as m/z 737. However, there are also differ-
ences in the mass spectra recorded by DESI and TS (Fig. 1A vs.
D, Fig. 1B vs. E). For example, chlorinated adducts of phos-
phatidylcholine species (e.g. m/z 794) are more abundant in
the TS than the DESI spectra (as well in the case of m/z 794
being more abundant in tumor than in normal tissue). This
example suggests that some differences between the ionization
methods can be attributed to different salt content tolerances
(TS has a lower salt tolerance than DESI) in the complex
matrix when analyzed with no sample pretreatment, as dis-
cussed elsewhere.8 The same spectra also show that the
average ion intensity in TS is two orders of magnitude greater
than that in DESI, suggesting that extraction/desorption occurs
more rapidly in comparison to DESI. Considering the lipid
profiles recorded for the entire dataset, 12 patients and 100
samples (thousands of mass spectra), the differences between
disease states are difficult to address by eye therefore a robust
statistical strategy is needed to efficiently explore the chemical
information contained in the mass spectra. PCA was
Fig. 1 (A) Average DESI-MS of normal prostate tissue samples (N = 74) from training set. (B) Average DESI-MS of prostate cancer tissue samples (N =
26) from training set. (C) Prostate tissue biopsy with outlined region of cancerous tissue which was analyzed by DESI imaging. (D) Average TS-MS of
normal prostate tissue samples (N = 74) from training set. (E) Average TS-MS of prostate cancer tissue samples (N = 26) from training set. (F) Prostate
tissue biopsy analyzed by TS-MS, tissue is adjacent to DESI imaged biopsy again the cancerous region outlined, the two missing regions correspond
to locations of TS-MS analysis.
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performed as an exploratory tool to identify chemical features
that characterize tumor and normal tissue based on the DESI
and TS lipid profiles. The PCA score plots are shown in Fig. 2A
and B, respectively for DESI and TS. Both plots show the
lowest-order principal components (PCs) for which separation
between normal and tumor tissue is apparent. Indeed, distinct
groupings of normal (dark green objects) and tumor tissue
samples (red objects) are present. The loading plots shown in
ESI† Fig. 1A and B display those lipids that contribute the
most to the PC differentiation.
The first principal component by definition encompasses
the largest variation in the multidimensional space of the orig-
inal variables, PC2 is orthogonal and includes the largest
remaining variation, etc. Separation in PC space between
normal and tumor tissue is interpreted in terms of differences
between their DESI (and TS) mass spectra (i.e. biochemical
features). The TS spectra are usually noisier than the DESI
spectra, which may be attributed to the smaller number of
scans acquired over a shorter time before signal exhaustion.
In this case, the best separation among red and dark green
objects is in the PC3 vs. PC4 score plot and is associated with
a slightly lower percentage of the total data variation. By con-
trast, DESI mass spectra result from averaging many pixels in
the hyperspectral images, selected as regions of interest
(tumor or normal tissue sections) and this helps reduce
random noise. In DESI, the best separation is along PC2
vs. PC3.
Independently of the ionization method used for analysis,
the loading plots display a similar relationship between the
objects and variables. This observation provides initial insight
into the consistency between DESI and TS in recovering the
biochemical features associated with the tumor/normal con-
dition. In particular, the ions m/z 835, 861, 885, and 887 are
higher in relative abundance in prostate cancer tissue, while
m/z 788 is higher in relative abundance in normal prostate
tissue. It is noteworthy that the ions observed in higher abun-
dance in prostate cancer tissue correspond to phosphatidyl-
inositol species: PhI(38:4), PhI(38:3), PhI(36:4), and PhI(34:5)
respectively. Oncogenes (e.g. PI3K, AKT, PTEN) pertaining to
lipid-based signaling are relevant to prostate and other human
cancers.26–28 Intriguingly, the dynamics in the PhI class of gly-
cerophospholipids could relate to PI3K, an oncogene which
utilizes phosphorylated-PhIs (not directly detected here) for
cancer cell growth and survival signaling.29 The observed
increase in non-phosphorylated PhIs might prove to have an
unexplored but important role in prostate cancer.
Classification of prostate cancer/normal tissue by molecular
profiling
LDA was performed on the DESI and TS target datasets (data
that was directly correlated to identified tumor or normal
samples by histopathology) to quantify the separation between
normal and tumor samples and build a classification model
capable of predicting the disease state of unknown samples.
The first eight and nine PCs were used for DESI and TS data-
sets, respectively, which provided the highest prediction rates
for both classes (normal and tumor tissue). The average cross-
validation (CV) prediction rate was 98% for DESI and 96% for
TS. The number of false results per class obtained through the
cross-validation process can be seen in Table 1, where the CV
confusion matrices are reported. Notably, DESI performs
slightly better than TS-MS, although both methods exceed
95% in correct predictions.
Table 1 Cross validation of training set
(A) DESI-MS CV prediction rates (C) TS-MS CV prediction rates
Normal 98.7% Normal 96.1%
Tumor 96.2% Tumor 95.8%
Average 97.5% Average 96%
(B) DESI-MS CV confusion
matrix
(D) TS-MS CV confusion matrix
Species Normal Tumor Species Normal Tumor
Normal 73 1 Normal 73 3
Tumor 1 25 Tumor 1 23
Fig. 2 (A) DESI-MS score plot, PC2 vs. PC3, displaying separation of
prostate cancer (red objects) and normal prostate tissue samples (dark
green objects). (B) TS-MS score plot, PC3 vs. PC4, displaying separation
of prostate cancer (red objects) and normal prostate tissue samples
(dark green objects).
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To further test the performance of TS-MS, which was used
here for the first time to differentiate diseased and healthy
tissue, an additional evaluation set was tested. Samples were
acquired from patients #13–18 and a total number of 70 biop-
sies were performed from which 110 samples were analyzed
randomly. The LDA model built on the target TS dataset was
used to predict the tissue condition (tumor or normal) of
these unknown samples. The LDA predictions, based on MS
molecular diagnostics, were compared with pathological evalu-
ation of adjacent, unanalysed, tissue sections. Nine samples
were diagnosed as prostate cancer by an expert pathologist,
while the remaining 101 samples were normal tissue. The LDA
results were only moderately discriminatory which we attribute
to the low reproducibility of some ions (e.g. chloride adducts)
in the TS evaluation set of spectra which were acquired in full
scan MS mode at a later date then the TS test set. We therefore
built an LDA model using the top five discriminant ions in the
range m/z 700–1000, as opposed to compressing the entire
mass spectra by PCA, using a stepwise variable selection strat-
egy to select the most discriminant ions.30 This strategy proved
more efficient and robust in differentiating tumor and normal
tissue for the TS target dataset (see Table 2), no prediction
errors in cross validation. Moreover, the average percentage of
correct prediction of tumor and normal tissue for the external
evaluation set (110 samples) was equal to 93%. It should be
noted that the small number of samples with tumor tissue was
due to the non-targeted selection of the samples analyzed.
These results suggest that further refinements of the strategy
used for data analysis could strengthen a decision-making
strategy based on molecular diagnostics. A wide portfolio of
pretreatment processes and variable selection techniques is
available for pattern recognition analysis, following the needs
of the acquired MS data structures.
DESI and TS similarities and fit-for-purpose applications
The similarities between DESI and TS mass spectra in provid-
ing chemical features associated with a healthy/disease state is
of interest. Indeed, although based on similar mechanisms of
ion generation (i.e. electrospray-like processes), DESI and TS
have specific analytical features that may be used to propose
diverse fit-for-purpose strategies of molecular diagnostics. To
estimate the correlation between the two sets of MS data, cano-
nical correlation analysis (CCA) was performed on the DESI
and TS target datasets (100 samples). Fig. 3 shows the samples
in the canonical variable space (1 vs. 2) for DESI and TS with a
clear separation between tumor (red) and normal tissue
samples (dark green). The correlation coefficients for the first
three canonical variables are as high as 0.94, 0.76, and 0.68
respectively (ESI† Fig. 2). The high correlation between DESI
and TS is also supported by the location of each sample
(labelled with the same sample number in both plots) in the
CCA space. The loading plots (ESI† Fig. 3) show the greatest
contribution to the canonical variable computation from prin-
cipal components 1, 2, and 3 for DESI, whereas principal com-
ponents 2, 3, and 4 have the highest contribution for TS. Most
importantly, the high correlation between DESI and TS data is
related to the principal components that carry the biochemical
information relevant to separating tumor and normal tissue
samples.
CCA results suggest that the same interpretations regarding
the chemical features which characterize tumor and normal
tissue can be applied to DESI and TS spectral patterns. This
suggests that both methods have similar diagnostic perform-
ance but with different, possibly complementary, implemen-
tations as now discussed. One of the most important features
Fig. 3 (A) Canonical variable 1 vs. 2 score plot displaying separation of
tumor (red objects) and normal tissue samples (dark green objects) for
DESI-MS target dataset. (B) Canonical variable 1 vs. 2 score plot display-
ing separation of tumor (red objects) and normal tissue samples (dark
green objects) for TS-MS target dataset.
Table 2 Validation of test set data
(A) TS-MS stepwise LDA on the
targeted dataset
(C) TS-MS untargeted prediction
rates
Normal 100% Normal 96%
Tumor 100% Tumor 89%
Average 100% Average 92.5%
(B) TS-MS stepwise LDA targeted
confusion matrix
(D) TS-MS untargeted confusion
matrix
Species Normal Tumor Species Normal Tumor
Normal 74 0 Normal 97 4
Tumor 0 26 Tumor 1 8
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of TS is its use of the probe as means of sampling a complex
matrix as well as serving as a source of the ions which move into
the mass spectrometer upon the addition of solvent and high
voltage. This transfer mechanism makes TS completely user-
guided and applicable to a variety of samples. TS is not limited
to tissue sections, but can be used to investigate areas of
interest in vivo. Fig. 4 shows the degree of similarity of (A) a
TS mass spectrum obtained by sampling a bisected radical
prostatectomy specimen in vitro and (B) a TS mass spectrum
obtained from a frozen tissue section from the training set.
The complete TS process of sampling to collecting data can
occur within 20 seconds. Similar lipid profiles are obtained for
DESI and TS, even though comparisons between in vitro and
in vivo TS analysis, as well as sources of contamination
affecting the mass spectra, e.g. blood, urine etc., need further
investigation.
Limited sample size is the main disadvantage of TS-MS.
The minimal removal of material from a sensitive source such
as tissue is viewed as an advantage for the patient, but it limits
the power of the technique by reducing analysis to a few MS
scans before the signal is exhausted. This could be overcome
by multiple examination of the same area, but each additional
sampling requires more time. The limited sample size col-
lected by the TS probe also forces the user to carefully consider
the measurement uncertainty due to sampling, which may
bias the analytical results.
TS-MS is envisioned as a surgical tool for disease screening of
areas of interest. As a surgical screening tool, TS could help pre-
serve healthy tissue that may have otherwise been resected for
histopathological evaluation or help with decisions to remove
additional diseased tissue that was observed to be questionable.
Conclusions
DESI-MS and TS-MS have been used to differentiate tumor and
normal tissue from biopsies taken from 18 radical prostatect-
omy surgical specimens. The targeted dataset (radical prosta-
tectomy specimen 1–12) was subjected to discriminant
classification analysis using LDA, providing an average predic-
tion rate of 97.5% for DESI-MS and 96% for TS-MS. Validation
of TS-MS as a non-targeted technique was performed using an
external evaluation set (radical prostatectomy specimen 13–18)
of unknown prostate specimens, which provided average pre-
dictions rates of 92.5%. DESI and TS results are comparable
(0.94 correlation coefficient by CCA), recovering the biochemi-
cal information, primarily in the lipids, that is responsible for
the separation of tumor and normal prostate tissue samples.
Experimental
Study protocols
Radical prostatectomy specimens #1–19 were obtained from
consented patients undergoing treatment at Indiana School of
Medicine (Indianapolis, IN) following an IRB approved study.
Biopsies were obtained from specimens #1–18 after resection
using a disposable biopsy gun (Max-core disposable core
biopsy instrument, Bard Biopsy Systems, Tempe, AZ). Biopsies
(approximately 4–15 mm × 1 mm × 1 mm) were subsequently
frozen, cryosectioned at 15 μm, and thaw mounted to glass
microscope slides. Sections were stored at −80 °C prior to MS
analysis. The same slide analyzed by DESI-MS imaging was
H&E stained and examined by an expert pathologist to identify
from tissue morphology the presence/absence of prostate
cancer. Adjacent sections (separated by ∼15–60 μm) were ana-
lyzed by TS-MS by sampling areas of 1–4 mm2 from regions of
known pathology based on the DESI/histopathology assign-
ment of locations as diseased or normal tissue. Note that this
procedure was necessary because TS is a destructive sampling
method for thin sections. Radical prostatectomy specimen #19
was inked according to IUSM gross pathology protocol then
bisected to allow the tissue to be analyzed in vitro. The speci-
men was analyzed by TS-MS at IUSM using an on-site commer-
cial mass spectrometer. No biopsies were taken from specimen
#19 and thus no DESI-MS analysis was performed. Radical
prostatectomy specimen #19 results were compared to gross
pathological analysis obtained from IUSM.
Fig. 4 (A) TS-MS obtained in vitro from radical prostatectomy case 19,
lipid pattern suggests sampled area was cancerous and this agrees with
gross pathology findings. (B) TS-MS obtained from targeted cancer
sample from training set.
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A total of 100 samples were prepared from patients # 1–12
and used to create a database of tumor and normal tissue
mass spectra for both DESI and TS methods. These databases
are referred to as targeted datasets, because the data used is
directly correlated with histopathological analysis of the tissue.
For the DESI targeted datasets, regions outlined as tumor or
normal by pathology were selected (∼4 mm2 on average) and
data were averaged to create each data point for subsequent
multivariate analysis. In parallel, TS was performed in the
regions outlined as tumor or normal tissue from adjacent
tissue sections used for DESI and that data was directly used
to create the TS targeted dataset. Table S1† shows in detail the
number of sections prepared per biopsy and patient. Another
70 biopsies were prepared from the other 6 radical prostatect-
omy specimens (patients # 13–18) and these were analyzed
only by TS-MS to create an evaluation dataset to further test
performance. The biopsy sections used to create this indepen-
dent evaluation dataset were randomly chosen and sampled
1–2 times (depending on the size of the tissue) to create a 110
sample dataset. Also included in the evaluation set were 1–2
randomly selected samples from each patient used in the tar-
geted dataset. Histopathology of these tissue sections was per-
formed after MS analysis on adjacent tissue (spacing
∼15–60 μm).
DESI-MS
A laboratory-built DESI ion source, similar to the commercial
2D source from Prosolia, Inc. (Indianapolis, IN, USA) was
coupled to a linear ion trap mass spectrometer (LTQ) con-
trolled by XCalibur 2.0 software (ThermoFisher Scientific,
Waltham, MA) and used in DESI experiments. The negative
ionization mode was used with the automatic gain control
(AGC) inactivated. The spray solvent used for DESI-MS was
dimethylformamide (DMF)–acetonitrile (ACN) at a 1 : 1 ratio
(v/v), both solvents were purchased from Mallinckrodt Baker
Inc. (Phillipsburg, NJ), and delivered at 1.0 μL min−1 flow rate
using the instrument syringe pump. The DESI source para-
meters were set as follows: capillary temperature 275 °C,
voltage applied to the stainless steel needle syringe 5 kV, capil-
lary voltage −25 V, tube lens voltage −115 V, capillary incident
angle 54°, spray to surface distance ∼3 mm, sample to inlet
distance ∼5 mm, and nitrogen gas at 180 PSI. Prostate tissue
sections were analyzed using a moving stage with a lateral
scan rate of 303.03 μm s−1 in horizontal rows separated by a
200 μm vertical step. Instrument scan time was coordinated
with scan speed providing ∼200 × 200 μm pixels. Full scan
mass spectra were acquired in negative ion mode in the mass
range m/z 200–1000. For statistical analysis of the evaluation
dataset, a reduced mass range of 700–1000 was used, limiting
the biochemical information to complex phospholipids.
Touch spray MS
The TS probe used was a commercially available teasing
needle purchased from Fisher Scientific (Pittsburgh, PA,
USA).7 Methanol (Mallinckrodt Baker Inc., Phillipsburg, NJ)
was used as spray solvent and 1 μL was applied manually via
an adjustable pipette (Eppendorf Research-2.5 μL). The LTQ
linear ion trap mass spectrometer was also used for the TS
experiments with the same operating parameters as those
used in the DESI experiments except that the voltage applied
to the TS probe was 4 kV and the automatic gain control was
active. TS was performed by touching and desorbing material
onto a teasing needle from regions of interest of 1–4 mm2.
After sampling, the tip of the probe was directed at the inlet of
the mass spectrometer and the high voltage and 1 μL of
solvent were applied. The extracted analytes were analyzed in a
spray time of ∼6 seconds. The data acquired within this period
were averaged to represent a single data point.
Principal component analysis of target datasets
An in-house program was used to convert the MS data files
(.raw) into ASCII files (.txt), which were imported into Matlab
(MathWorks, Inc., Natick, USA). Biomap software (http://www.
maldi-msi.org) was used to display single ion images (i.e.
spatial distribution of a single m/z variable, ESI† Fig. 4) with
MS intensity represented in false color (normalized to the
absolute value). For each DESI image, information was coded
as a datacube (X·Y·MS), where “X” and “Y” are spatial dimen-
sions and the “MS” domain contains the m/z variables and
corresponding intensity (i.e. an entire mass spectrum). Group-
ings of adjacent pixels, i.e. regions-of-interest (ROIs), repre-
senting areas of tumor or normal tissue were selected in the
2D spatial domain (X·Y), according to pathological evaluations,
and the corresponding mass spectra were averaged. The aver-
aged mass spectra from the prostate sections constituted the
DESI target dataset. The TS target dataset was built using a list
of m/z values and ion abundances from the average mass spec-
trum (over ∼6 s of data acquisition) acquired per sample. The
data were then imported into Matlab.
The acquisition step used to increment m/z values was
equal to 0.0833, therefore the two data matrices (DESI and TS)
consisted of 3601 columns (i.e. m/z values) and 100 rows (i.e.
samples: normal tissue sections, n = 74; tumor tissue sections,
n = 26). PCA was performed with in-house Matlab routines.
PCA is commonly used for exploring complex information con-
tained within mass spectral datasets, allowing consideration of
all spectral variables and possible inter-correlations simul-
taneously.25,31 By means of PCA, the information of the origi-
nal m/z variables is reorganized and compacted in a few
principal components (PCs). That is, PCA can be used as an
unsupervised data compression technique. When dealing with
high-dimensional data, the compression of the relevant infor-
mation is a preliminary step in order to efficiently manage and
extract useful features. All MS spectra were normalized by the
standard normal variate (SNV) transform, correcting for both
baseline shifts and global intensity variations,32,33 and then
column centered. The principal components are orthogonal
(i.e. uncorrelated) and efficiently describe large fractions of the
information. The projections of the data objects onto the PCs
are called scores, while the importance of each original vari-
able in defining a certain PC is given by a loading coefficient.
Groupings in the score plot indicate similarities among
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the objects (i.e. samples), based on the information derived
from the mass spectra. Both scores and loading values were
represented in two-dimensional scatter plots.
Canonical correlation analysis on the target datasets
Canonical correlation analysis (CCA) is a way of measuring the
linear relationship between two multidimensional variables
(DESI and TS) observed on the same sample collection.34,35 In
this study, the two datasets represent the DESI and TS mass
spectra recorded from 100 prostate tissue sections. The DESI
mass spectral dataset is considered as a reference. CCA rotates
the original variables in the two blocks, to obtain some pairs
of variables (one for each block), called canonical variables,
with maximum correlation between the two blocks. The
dimensionality of these new bases is equal to or less than the
smallest dimensionality of the two sets of variables. The cano-
nical variables are linear combinations of the original auto-
scaled (i.e. unitary variance) variables, whose contribution in
defining a specific canonical variable can be inferred through
the corresponding loading value. The correlation coefficients
between the DESI canonical variable and the corresponding TS
canonical variable are termed canonical correlation coeffi-
cients. Specific details on CCA can be found elsewhere.34,35 In
order to overcome the high inter-correlations across m/z
values, CCA was performed after PCA, which acts as an un-
supervised data compression technique. Two separate PCAs
were run on the SNV normalized and column-centered DESI
and TS mass spectral data. The first 10 PCs, explaining about
90% of total data variation, were selected and used for CCA.
CCA was performed by the free chemometric package
V-PARVUS 2010 (University of Genova, Italy, (http://www.csita.
unige.it/software/free/other.html).
Linear discriminant analysis on the target and the evaluation
sets
Linear discriminant analysis (LDA) was performed as a super-
vised discriminant classification technique. Discriminant
methods look for a delimiter that divides the global domain
into a number of regions, each assigned to one of the classes.
This delimiter identifies an open region for each class and
such regions determine the assignment of the samples to one
of the classes.30,36 Model validation (i.e. evaluation of the pre-
dictive ability of the model) was performed by means of cross
validation (CV).36 For this study, five cross-validation deletion
groups were selected, meaning that all the samples (n = 100)
were divided five times systematically in a training set (objects
used for building the classification model) and a test set
(remaining objects used to evaluate the predictive ability of the
model), with all the samples being in the test set only once.
Eventually, the final model was built using all the objects. LDA
was applied on the DESI and TS target datasets of SNV normal-
ized mass spectra after compression by PCA, thereby using as
variables the principal components (instead of the original
mass spectral data). Two classes were modelled: normal tissue
(n = 74) and tumor (n = 26). In more detail, 8 PCs for DESI and
9 PCs for TS were computed each time with the training
samples and used for building the classification model. The
test sets – samples that did not contribute in the model build-
ing process – were used to estimate the global prediction rate
for all classes, hence as the CV prediction rate for each class.
This is a so-called complete validation strategy.36 The CV pre-
diction rate is the percentage of correct predictions on the
objects in the CV test sets. The CV confusion matrix shows
how many samples belonging to a certain category were cor-
rectly/incorrectly assigned by the classification rule to that cat-
egory. Indeed, in this matrix, each element gives the number
of samples of the row category assigned to the column cat-
egory. When the matrix is diagonal (entries outside the main
diagonal are all zero) there is a perfect prediction of all the
samples. Note that LDA models used for supervised discrimi-
nant classification were built by using 4 to 10 PCs. The models
with 8 and 9 PCs, for DESI and TS respectively, were chosen as
they provided the least number of false results (i.e. highest pre-
diction rates) in cross-validation.
The model built for the TS dataset was used further to
predict the normal/disease state of another 110 samples (the
evaluation set), whose histopathology was unknown at the
time of MS analysis. The subsequent comparison between
molecular diagnosis by TS-MS and histological diagnosis
further validated the TS-MS model performances. LDA was per-
formed with Matlab using in-house routines.
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